[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,805,851,921,1009,1068,1124,1368,1415],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":28,"verifyTime":776,"verifyNote":784,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":785,"fullTextUrl":26,"authors":786,"publicationType":747,"publisherRelationship":787,"citationCount":26,"citationInfo":26,"publishDate":803,"publishYear":804,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"f1ea3096-45fd-4619-a03a-153929dcf569","2023-12-09T22:02:25.273+00:00","2025-01-22T16:58:18.456+00:00",[],"Cirug%C3%ADa-de-los-tumores-epiteliales-malignos-del-ovario",{"title":780,"doi":782},{"EN":781},"Cirugía de los tumores epiteliales malignos del ovario",{"VOID":783},"10.1016\u002FS1283-081X(10)70778-5","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X10707785",[],{"url":785,"publisher":788,"properties":796},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":789,"slug":662,"properties":790,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":793,"manageAffiliations":794,"indexDatabases":795,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":791,"title":792},{"VOID":665},{"EN":667},[],[],[],{"volume":797,"pages":799,"issue":801},{"VOID":798},"46",{"VOID":800},"1-16",{"VOID":802},"1","2010-01-01",2010,{"id":806,"createTime":807,"updateTime":808,"relativeEntities":809,"slug":810,"properties":811,"entityType":688,"verifyStatus":25,"verifyTime":808,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":818,"fullTextUrl":26,"authors":819,"publicationType":747,"publisherRelationship":835,"citationCount":26,"citationInfo":26,"publishDate":849,"publishYear":850,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"f271ac4d-1ee7-424a-a296-e83bbfdf1897","2024-02-07T18:51:08.944+00:00","2025-01-26T18:25:54.467+00:00",[],"Estomatolog%C3%ADa-y-embarazo",{"references":812,"title":814,"doi":816},{"VOID":813},"Engineer, 2000, Pemphigoid gestationis: a review, Am J Obstet Gynecol, 183, 483, 10.1067\u002Fmob.2000.105430\nHou, 1988, Primary gingival enlargement as a diagnostic indicatorin acute myelomonocytic leukemia. A case report, J Periodontol, 59, 852, 10.1902\u002Fjop.1988.59.12.852\nJeffcoat, 2001, Periodontal infection and preterm birth: results of a prospective study, J Am Dent Assoc, 132, 875, 10.14219\u002Fjada.archive.2001.0299\nLivingston, 1998, Considerations in the management of the pregnant patient, Spec Core Dent, 18, 183, 10.1111\u002Fj.1754-4505.1998.tb01737.x\nMcCann, 2001, Maintening women's oral health, Dent Clin North Am, 45, 571, 10.1016\u002FS0011-8532(22)00544-4\nMachuca, 1999, The influence of general health and socio-cultural variables on the periodontal condition of pregnant women, J Periodontol, 70, 779, 10.1902\u002Fjop.1999.70.7.779\nMirochnick, 2000, Antiretroviral pharmacology in pregnant women and their newborns, Ann NY Acad Sci, 918, 287, 10.1111\u002Fj.1749-6632.2000.tb05498.x\nOjanotko-Harri, 1991, Altered tissue metabolism of progesterone in pregnancy gingivitis and granuloma, J Clin Periodontol, 18, 262, 10.1111\u002Fj.1600-051X.1991.tb00425.x\nWang, 1997, Severe bleeding from a pregnancy tumor. A case report, J Reprod Med, 42, 359",{"ES":815},"Estomatología y embarazo",{"VOID":817},"10.1016\u002Fs1283-081x(02)71903-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X02719036",[820],{"id":821,"sortIndex":36,"researcher":26,"roles":822,"affiliations":823,"properties":832},"1139b55e-8e2c-4c0f-afb1-ef0aa88d72af",[696],[824],{"id":26,"sortIndex":36,"affiliation":825,"properties":26},{"id":826,"createTime":827,"updateTime":827,"relativeEntities":828,"slug":26,"properties":829,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"afe45147-3f4a-4405-9086-741de2c2b2f9","2024-02-07T18:51:08.960+00:00",[],{"title":830},{"VI":831},"service de stomatologie et de chirurgie maxillofaciale du professeur Jean-Charles Bertrand, groupe hospitalier Pitié-Salpêtrière, 47-83, boulevard de l'Hdpital, 75013 Paris, France",{"title":833},{"VI":834},"Scarlette Agbo-Godeau",{"url":818,"publisher":836,"properties":844},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":837,"slug":662,"properties":838,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":841,"manageAffiliations":842,"indexDatabases":843,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":839,"title":840},{"VOID":665},{"EN":667},[],[],[],{"volume":845,"pages":847},{"VOID":846},"38",{"VOID":848},"1-4","2002-01-01",2002,{"id":852,"createTime":853,"updateTime":854,"relativeEntities":855,"slug":856,"properties":857,"entityType":688,"verifyStatus":25,"verifyTime":854,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":864,"fullTextUrl":26,"authors":865,"publicationType":747,"publisherRelationship":905,"citationCount":26,"citationInfo":26,"publishDate":919,"publishYear":920,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"b01aff45-1715-4944-8358-bf5ecf6e69ef","2024-01-12T04:08:28.664+00:00","2024-12-05T23:50:18.874+00:00",[],"Recidiva-locorregional-del-c%C3%A1ncer-de-mama",{"references":858,"title":860,"doi":862},{"VOID":859},"Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. 2019. https:\u002F\u002Fwww.santepubliquefrance.fr\u002Fmaladies-et-traumatismes\u002Fcancers\u002Fcancer-du-sein\u002Fdocuments\u002Frapport-synthese\u002Festimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaineentre-1990-et-2018-volume-1-tumeurs-solides-etud.\nAnderson, 2009, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer, J Clin Oncol, 27, 2466, 10.1200\u002FJCO.2008.19.8424\nAndry, 1989, Locoregional recurrences after 649 modified radical mastectomies: incidence and significance, Eur J Surg Oncol, 15, 476\nArriagada, 2002, Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer, Ann Oncol, 13, 1404, 10.1093\u002Fannonc\u002Fmdf227\nClemons, 2001, Locoregionally recurrent breast cancer: incidence, risk factors and survival, Cancer Treat Rev, 27, 67, 10.1053\u002Fctrv.2000.0204\nFortin, 1999, Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy, J Clin Oncol, 17, 101, 10.1200\u002FJCO.1999.17.1.101\nSchmoor, 2000, Role of isolated locoregional recurrence of breast cancer: results of four prospective studies, J Clin Oncol, 18, 1696, 10.1200\u002FJCO.2000.18.8.1696\nWapnir, 2006, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials, J Clin Oncol, 24, 2028, 10.1200\u002FJCO.2005.04.3273\nTaghian, 2004, J Clin Oncol, 22, 4247, 10.1200\u002FJCO.2004.01.042\nFisher, 1991, Significance of ipsilateral breast tumour recurrence after lumpectomy, Lancet, 338, 327, 10.1016\u002F0140-6736(91)90475-5\nFisher, 1992, Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP protocol B-06, Semin Surg Oncol, 8, 161\nVeronesi, 1995, Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events, J Natl Cancer Inst, 87, 19, 10.1093\u002Fjnci\u002F87.1.19\nFisher, 2002, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, 1233, 10.1056\u002FNEJMoa022152\nGalper, 2005, Prognosis after local recurrence after conservative surgery and radiation for earlystage breast cancer, Int J Radiat Oncol Biol Phys, 61, 348, 10.1016\u002Fj.ijrobp.2004.06.011\nLe, 2002, Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma, Cancer, 94, 2813, 10.1002\u002Fcncr.10572\nSalvadori, 1999, Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery, Br J Surg, 86, 84, 10.1046\u002Fj.1365-2168.1999.00961.x\nClarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016\u002FS0140-6736(05)67887-7\nBlichert-Toft, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group, J Natl Cancer Inst Monogr, 19\nJacobson, 1995, Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer, N Engl J Med, 332, 907, 10.1056\u002FNEJM199504063321402\nSarrazin, 1989, Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer, Radiother Oncol, 14, 177, 10.1016\u002F0167-8140(89)90165-5\nvan Dongen, 2000, Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial, J Natl Cancer Inst, 92, 1143, 10.1093\u002Fjnci\u002F92.14.1143\nVeronesi, 2002, Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056\u002FNEJMoa020989\nMannino, 2009, Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld?, Radiotherapy and Oncology, 90, 14, 10.1016\u002Fj.radonc.2008.05.002\nHuang, 2002, Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences, Cancer, 95, 2059, 10.1002\u002Fcncr.10952\nKomoike, 2005, Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors, Breast Cancer, 12, 104, 10.2325\u002Fjbcs.12.104\nPanet-Raymond, 2011, True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy, Int J Radiat Oncol Biol Phys, 81, 409, 10.1016\u002Fj.ijrobp.2010.05.063\nYi, 2011, Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning, Ann Surg, 253, 572, 10.1097\u002FSLA.0b013e318208fc2a\nYoshida, 2010, True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment, Breast J, 16, 127, 10.1111\u002Fj.1524-4741.2009.00884.x\nBollet, 2008, High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers, J Natl Cancer Inst, 100, 48, 10.1093\u002Fjnci\u002Fdjm266\nVicini, 2007, The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy, Cancer, 109, 1264, 10.1002\u002Fcncr.22529\nSmith, 2000, True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, Int J Radiat Oncol Biol Phys, 48, 1281, 10.1016\u002FS0360-3016(00)01378-X\nWoodward, 2010, Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival, Breast Cancer Res Treat, 123, 597, 10.1007\u002Fs10549-010-0829-8\nBuchanan, 2006, Locoregional recurrence after mastectomy: incidence and outcomes, J Am Coll Surg, 203, 469, 10.1016\u002Fj.jamcollsurg.2006.06.015\nWapnir, 2008, Progress on BIG 1-02\u002FIBCSG 27-02\u002FNSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer, Ann Surg Oncol, 15, 3227, 10.1245\u002Fs10434-008-0129-2\nHarris, 2003, Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy, Cancer, 98, 2144, 10.1002\u002Fcncr.11767\nReddy, 2010, Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and Doxorubicin-based chemotherapy for breast cancer, Int J Radiat Oncol Biol Phys, 80, 1453, 10.1016\u002Fj.ijrobp.2010.04.015\nJaffre, 2009, Prognosis for isolated skin recurrence after breast cancer treated by mastectomy, Anticancer Res, 29, 1697\nBurstein, 2004, Ductal carcinoma in situ of the breast, N Engl J Med, 350, 1430, 10.1056\u002FNEJMra031301\nBoyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002\u002F(SICI)1097-0142(19990201)85:3\u003C616::AID-CNCR12>3.0.CO;2-7\nWapnir, 2011, Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS, J Natl Cancer Inst, 103, 478, 10.1093\u002Fjnci\u002Fdjr027\nBijker, 2006, J Clin Oncol, 24, 3381, 10.1200\u002FJCO.2006.06.1366\nFisher, 2001, Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience, Semin Oncol, 28, 400, 10.1016\u002FS0093-7754(01)90133-2\nHolmberg, 2008, Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast, J Clin Oncol, 26, 1247, 10.1200\u002FJCO.2007.12.7969\nHoughton, 2003, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet, 362, 95\nViani, 2007, Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiat Oncol, 2, 28, 10.1186\u002F1748-717X-2-28\nSilverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056\u002FNEJM199905133401902\nSilverstein, 1996, A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 2267, 10.1002\u002F(SICI)1097-0142(19960601)77:11\u003C2267::AID-CNCR13>3.0.CO;2-V\nWong, 2006, Prospective study of wide excision alone for ductal carcinoma in situ of the breast, J Clin Oncol, 24, 1031, 10.1200\u002FJCO.2005.02.9975\nHughes, 2009, Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 27, 5319, 10.1200\u002FJCO.2009.21.8560\nMotwani, 2011, Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194, Cancer, 117, 1156, 10.1002\u002Fcncr.25623\nMeattini, 2017, Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: long-term experience from two large-institutional series, Breast, 33, 139, 10.1016\u002Fj.breast.2017.03.017\nTay, 2020, Impact of hormonal status on ductal carcinoma in situ of the breast: outcome and prognostic factors, Breast J, 26, 937, 10.1111\u002Ftbj.13738\nWu, 2020, Recurrence outcomes after nipple-sparing mastectomy and immediate breast reconstruction in patients with pure ductal carcinoma in situ, Ann Surg Oncol, 27, 1627, 10.1245\u002Fs10434-019-08184-z\nMarinovich, 2016, The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 23, 3811, 10.1245\u002Fs10434-016-5446-2\nSigal-Zafrani, 2004, Histological margin assessment for breast ductal carcinoma in situ: precision and implications, Mod Pathol, 17, 81, 10.1038\u002Fmodpathol.3800019\nvan la Parra, 2019, Oncoplastic level 2 mammoplasty for large DCIS: 5-year results, Ann Surg Oncol, 26, 2459, 10.1245\u002Fs10434-019-07423-7\nKrag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016\u002FS1470-2045(07)70278-4\nVeronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056\u002FNEJMoa012782\nKrag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016\u002FS1470-2045(10)70207-2\nNaik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a followup study of 4008 procedures, Ann Surg, 240, 462, 10.1097\u002F01.sla.0000137130.23530.19\nvan der Ploeg, 2008, Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature, Eur J Surg Oncol, 34, 1277, 10.1016\u002Fj.ejso.2008.01.034\nDel Bianco, 2008, Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial, Eur J Surg Oncol, 34, 508, 10.1016\u002Fj.ejso.2007.05.017\nFisher, 1981, The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet, 152, 765\nGoyal, 2004, Predictors of non-sentinel lymph node metastasis in breast cancer patients, Eur J Cancer, 40, 1731, 10.1016\u002Fj.ejca.2004.04.006\nHwang, 2003, Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer, Ann Surg Oncol, 10, 248, 10.1245\u002FASO.2003.05.020\nNos, 2003, Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases, Br J Surg, 90, 1354, 10.1002\u002Fbjs.4325\nAlran, 2007, Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy, Ann Surg Oncol, 14, 2195, 10.1245\u002Fs10434-006-9331-2\nCoutant, 2009, Validation of the Tenon breast cancer score for predicting nonsentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study, Breast Cancer Res Treat, 113, 537, 10.1007\u002Fs10549-008-9967-7\nHouvenaeghel, 2009, A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis, Eur J Surg Oncol, 35, 690, 10.1016\u002Fj.ejso.2008.10.003\nKimberly, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245\u002FASO.2003.03.015\nGrube, 2001, Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial, Semin Surg Oncol, 20, 230, 10.1002\u002Fssu.1038\nGiuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001\u002Fjama.2011.90\nGiuliano, 2017, Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial, JAMA, 318, 918, 10.1001\u002Fjama.2017.11470\nGalimberti, 2018, Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year followup of a randomised, controlled phase 3 trial, Lancet Oncol, 19, 1385, 10.1016\u002FS1470-2045(18)30380-2\nde Boniface, 2017, Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial, BMC Cancer, 17, 379, 10.1186\u002Fs12885-017-3361-y\nBeadle, 2009, Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach, Int J Radiat Oncol Biol Phys, 73, 734, 10.1016\u002Fj.ijrobp.2008.04.078\nTruong, 2009, Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy, Int J Radiat Oncol Biol Phys, 73, 357, 10.1016\u002Fj.ijrobp.2008.04.034\nVoogd, 2001, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials, J Clin Oncol, 19, 1688, 10.1200\u002FJCO.2001.19.6.1688\nGentilini, 2007, When can a second conservative approach be considered for ipsilateral breast tumour recurrence?, Ann Oncol, 18, 468, 10.1093\u002Fannonc\u002Fmdl424\nOh, 2006, The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is ‘young’?, Int J Radiat Oncol Biol Phys, 65, 1345, 10.1016\u002Fj.ijrobp.2006.03.028\nGarg, 2007, Effect of postmastectomy radiotherapy in patients \u003C 35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy, Int J Radiat Oncol Biol Phys, 69, 1478, 10.1016\u002Fj.ijrobp.2007.05.029\nPark, 2009, High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer, Int J Radiat Oncol Biol Phys, 73, 75, 10.1016\u002Fj.ijrobp.2008.04.007\nEwertz, 2011, Effect of obesity on prognosis after early-stage breast cancer, J Clin Oncol, 29, 25, 10.1200\u002FJCO.2010.29.7614\nGabos, 2010, The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer, Breast Cancer Res Treat, 124, 187, 10.1007\u002Fs10549-010-1135-1\nLi, 2011, Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 chinese breast cancer cases, Ann Surg Oncol, 18, 2492, 10.1245\u002Fs10434-011-1626-2\nSinn, 1998, Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy, Eur J Cancer, 34, 646, 10.1016\u002FS0959-8049(97)10106-X\nHolland, 1990, The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast, J Clin Oncol, 8, 113, 10.1200\u002FJCO.1990.8.1.113\nAlbert, 2010, Estrogen\u002Fprogesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer, Int J Radiat Oncol Biol Phys, 77, 1296, 10.1016\u002Fj.ijrobp.2009.12.011\nPanoff, 2011, Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation, Breast Cancer Res Treat, 128, 899, 10.1007\u002Fs10549-011-1495-1\nVoduc, 2010, Breast cancer subtypes and the risk of local and regional relapse, J Clin Oncol, 28, 1684, 10.1200\u002FJCO.2009.24.9284\nMeyers, 2011, Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer, Ann Surg Oncol, 18, 2851, 10.1245\u002Fs10434-011-1665-8\nMontagna, 2012, Breast cancer subtypes and outcome after local and regional relapse, Ann Oncol, 23, 324, 10.1093\u002Fannonc\u002Fmdr129\nFreedman, 2009, Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation, Cancer, 115, 946, 10.1002\u002Fcncr.24094\nAlbert, 2011, Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer, Cancer, 117, 1595, 10.1002\u002Fcncr.25694\nWapnir, 2018, Efficacy of chemotherapy for ER-Negative and ER-Positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR trial, J Clin Oncol, 36, 1073, 10.1200\u002FJCO.2017.76.5719\nPan, 2017, 20-Year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years, N Engl J Med, 377, 1836, 10.1056\u002FNEJMoa1701830\nLowery, 2012, Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype, Breast Cancer Res Treat, 133, 831, 10.1007\u002Fs10549-011-1891-6\nZumsteg, 2013, Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer, Ann Surg Oncol, 20, 3469, 10.1245\u002Fs10434-013-3011-9\nChen, 2017, Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer, Adv Radiat Oncol, 2, 105, 10.1016\u002Fj.adro.2017.01.012\nWang, 2010, Triplenegative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy, Int J Radiat Oncol Biol Phys, 80, 1095, 10.1016\u002Fj.ijrobp.2010.03.038\nKwan, 2010, Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1-2pN0 disease?, Ann Oncol, 21, 988, 10.1093\u002Fannonc\u002Fmdp396\nMamounas, 2010, Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20, J Clin Oncol, 28, 1677, 10.1200\u002FJCO.2009.23.7610\nMamounas, 2017, 21-Gene recurrence score and locoregional recurrence in nodepositive\u002Fer-positive breast cancer treated with chemo-endocrine therapy, J Natl Cancer Inst, 109, 10.1093\u002Fjnci\u002Fdjw259\nTurashvili, 2017, 21-Gene recurrence score and locoregional recurrence in lymph nodenegative, estrogen receptor-positive breast cancer, Breast Cancer Res Treat, 166, 69, 10.1007\u002Fs10549-017-4381-7\nBidard, 2009, Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer, Ann Oncol, 20, 1836, 10.1093\u002Fannonc\u002Fmdp200\nHoussami, 2010, Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy, Eur J Cancer, 46, 3219, 10.1016\u002Fj.ejca.2010.07.043\nAziz, 2006, The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer, Breast J, 12, 331, 10.1111\u002Fj.1075-122X.2006.00271.x\nChagpar, 2004, Lumpectomy margins are affected by tumor size and histologic subtype but not by biopsy technique, Am J Surg, 188, 399, 10.1016\u002Fj.amjsurg.2004.06.020\nMoore, 2000, Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy, Ann Surg, 231, 877, 10.1097\u002F00000658-200006000-00012\nvan Deurzen, 2016, Predictors of surgical margin following breastconserving surgery: a large population-based cohort study, Ann Surg Oncol, 23, 627, 10.1245\u002Fs10434-016-5532-5\nPleijhuis, 2013, A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making, Breast, 22, 773, 10.1016\u002Fj.breast.2013.01.010\nHeil, 2012, Do reexcisions impair aesthetic outcome in breast conservation surgery? Exploratory analysis of a prospective cohort study, Ann Surg Oncol, 19, 541, 10.1245\u002Fs10434-011-1947-1\nGagliato Dde, 2014, Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer, J Clin Oncol, 32, 735, 10.1200\u002FJCO.2013.49.7693\nHennigs, 2016, Do patients after reexcision due to involved or close margins have the same risk of local recurrence as those after one-step breast-conserving surgery?, Ann Surg Oncol, 23, 1831, 10.1245\u002Fs10434-015-5067-1\nHolland, 1985, Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery, Cancer, 56, 979, 10.1002\u002F1097-0142(19850901)56:5\u003C979::AID-CNCR2820560502>3.0.CO;2-N\nFitzgerald, 2016, Close and positive lumpectomy margins are associated with similar rates of residual disease with additional surgery, Ann Surg Oncol, 23, 4270, 10.1245\u002Fs10434-016-5490-y\nGarvey, 2015, Rates of residual disease with close but negative margins in breast cancer surgery, Breast, 24, 413, 10.1016\u002Fj.breast.2015.03.005\nDemirci, 2012, Breast conservation therapy: the influence of molecular subtype and margins, Int J Radiation Oncol Biol Physics, 83, 814, 10.1016\u002Fj.ijrobp.2011.09.001\nJones, 2009, Impact of pathological characteristics on local relapse after breastconserving therapy: a subgroup analysis of the EORTC boost versus no boost trial, J Clin Oncol, 27, 4939, 10.1200\u002FJCO.2008.21.5764\nHoussami, 2014, The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis, Ann Surg Oncol, 21, 717, 10.1245\u002Fs10434-014-3480-5\nMoran, 2014, Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer, J Clin Oncol, 32, 1507, 10.1200\u002FJCO.2013.53.3935\nVaidya, 2020, Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial, BMJ, 370\nCuzick, 2011, Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\u002FANZ DCIS trial, Lancet Oncol, 12, 21, 10.1016\u002FS1470-2045(10)70266-7\nPetrelli, 2011, Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials, Radiother Oncol, 100, 195, 10.1016\u002Fj.radonc.2011.02.005\nMauri, 2005, Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, 97, 188, 10.1093\u002Fjnci\u002Fdji021\nBuzdar, 2005, Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer, J Clin Oncol, 23, 3676, 10.1200\u002FJCO.2005.07.032\nLiedtke, 2008, Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, 26, 1275, 10.1200\u002FJCO.2007.14.4147\nChen, 2004, Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, 22, 2303, 10.1200\u002FJCO.2004.09.062\nBroecker, 2017, Neoadjuvant therapy combined with oncoplastic reduction for high-stage breast cancer patients, Ann Plast Surg, 78, S258, 10.1097\u002FSAP.0000000000001062\nMazouni, 2013, The role of oncoplastic breast surgery in the management of breast cancer treated with primary chemotherapy, Breast, 22, 1189, 10.1016\u002Fj.breast.2013.07.055\nAlpert, 2005, Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation, Int J Radiat Oncol Biol Phys, 63, 845, 10.1016\u002Fj.ijrobp.2005.02.035\nSchnitt, 1985, Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance, Int J Radiat Oncol Biol Phys, 11, 1277, 10.1016\u002F0360-3016(85)90242-1\nKurtz, 1991, Is breast conservation after local recurrence feasible?, Cancer, 27, 240\nVoogd, 1999, Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local recurrence after breast conservation (BORST), Eur J Cancer, 35, 1828, 10.1016\u002FS0959-8049(99)00220-8\nSellam, 2019, Local recurrence of breast cancer: salvage lumpectomy as an option for local treatment, Breast J, 25, 619, 10.1111\u002Ftbj.13290\nKuerer, 2004, Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation, Cancer, 100, 2269, 10.1002\u002Fcncr.20257\nDeutsch, 2002, Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation, Int J Radiat Oncol Biol Phys, 53, 687, 10.1016\u002FS0360-3016(02)02785-2\nChadha, 2008, The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer, Brachytherapy, 7, 22, 10.1016\u002Fj.brachy.2007.10.006\nHannoun-Levi, 2013, Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group, Radiother Oncol, 108, 226, 10.1016\u002Fj.radonc.2013.03.026\nHannoun-Levi, 2011, Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction, Brachytherapy, 10, 171, 10.1016\u002Fj.brachy.2010.05.004\nHannoun-Levi, 2004, Partial breast irradiation as second conservative treatment for local breast cancer recurrence, Int J Radiat Oncol Biol Phys, 60, 1385, 10.1016\u002Fj.ijrobp.2004.05.035\nResch, 2002, Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy. a second chance to preserve the breast1, Radiology, 225, 713, 10.1148\u002Fradiol.2253011913\nTrombetta, 2008, Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience, Brachytherapy, 7, 29, 10.1016\u002Fj.brachy.2007.12.001\nVavassori, 2020, High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study, J Contemp Brachytherapy, 12, 207, 10.5114\u002Fjcb.2020.96860\nKuo, 2008, Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence, Int J Radiat Oncol Biol Phys, 72, 1456, 10.1016\u002Fj.ijrobp.2008.03.042\nMaaskant-Braat, 2013, Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature, Breast Cancer Res Treat, 138, 13, 10.1007\u002Fs10549-013-2409-1\nVugts, 2015, Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer, Ann Surg Oncol, 22, S529, 10.1245\u002Fs10434-015-4787-6\nVugts, 2015, Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer, Breast Cancer Res Treat, 153, 549, 10.1007\u002Fs10549-015-3571-4\nBeck, 1983, Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients, J Clin Oncol, 1, 400, 10.1200\u002FJCO.1983.1.6.400\nHalverson, 1992, Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy, Am J Clin Oncol, 15, 93, 10.1097\u002F00000421-199204000-00001\nJanjan, 1986, Management of locoregional recurrent breast cancer, Cancer, 58, 1552, 10.1002\u002F1097-0142(19861001)58:7\u003C1552::AID-CNCR2820580728>3.0.CO;2-W\nRauschecker, 2001, Systemic therapy for treating locoregional recurrence in women with breast cancer, Cochrane Database Syst Rev, CD002195\nWaeber, 2003, Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\u002F82) comparing tamoxifen with observation, Ann Oncol, 14, 1215, 10.1093\u002Fannonc\u002Fmdg347",{"ES":861},"Recidiva locorregional del cáncer de mama",{"VOID":863},"10.1016\u002Fs1283-081x(22)46718-x","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X2246718X",[866,881,893],{"id":867,"sortIndex":115,"researcher":26,"roles":868,"affiliations":869,"properties":878},"5635d257-5426-4a90-918d-397a90d7f98a",[696],[870],{"id":26,"sortIndex":36,"affiliation":871,"properties":26},{"id":872,"createTime":873,"updateTime":873,"relativeEntities":874,"slug":26,"properties":875,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a40fbfc9-f226-4942-b18d-08639538be21","2024-01-12T04:08:28.851+00:00",[],{"title":876},{"VI":877},"Département de chirurgie oncologique, ICM Val d’Aurelle, rue de la Croix-Verte, 34298 Montpellier, France",{"title":879},{"VI":880},"C. Taoum",{"id":882,"sortIndex":36,"researcher":26,"roles":883,"affiliations":884,"properties":890},"088b5668-ccf2-4ccc-9e1f-710a39ebbf98",[696],[885],{"id":26,"sortIndex":36,"affiliation":886,"properties":26},{"id":872,"createTime":873,"updateTime":873,"relativeEntities":887,"slug":26,"properties":888,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":889},{"VI":877},{"title":891},{"VI":892},"P.-E. Colombo",{"id":894,"sortIndex":114,"researcher":26,"roles":895,"affiliations":896,"properties":902},"997809e6-5134-4187-8c55-2df934ca2a6c",[696],[897],{"id":26,"sortIndex":36,"affiliation":898,"properties":26},{"id":872,"createTime":873,"updateTime":873,"relativeEntities":899,"slug":26,"properties":900,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":901},{"VI":877},{"title":903},{"VI":904},"P. Rouanet",{"url":864,"publisher":906,"properties":914},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":907,"slug":662,"properties":908,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":911,"manageAffiliations":912,"indexDatabases":913,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":909,"title":910},{"VOID":665},{"EN":667},[],[],[],{"volume":915,"pages":917},{"VOID":916},"58",{"VOID":918},"1-20","2022-07-01",2022,{"id":922,"createTime":923,"updateTime":924,"relativeEntities":925,"slug":926,"properties":927,"entityType":688,"verifyStatus":25,"verifyTime":924,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":934,"fullTextUrl":26,"authors":935,"publicationType":747,"publisherRelationship":993,"citationCount":26,"citationInfo":26,"publishDate":1007,"publishYear":1008,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"6295d359-68af-4766-aaf7-4883bc9227ad","2023-12-28T21:25:20.387+00:00","2025-02-09T18:50:52.785+00:00",[],"C%C3%A1ncer-de-endometrio",{"references":928,"title":930,"doi":932},{"VOID":929},"Jemal, 2005, Cancer statistics, 2005, CA Cancer J. Clin., 55, 10, 10.3322\u002Fcanjclin.55.1.10\nMadison, 2004, Endometrial cancer: socioeconomic status and racial\u002Fethnic differences in stage at diagnosis, treatment, and survival, Am. J. Public Health, 94, 2104, 10.2105\u002FAJPH.94.12.2104\nGershenson, 2004\nCalle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults, N. Engl. J. Med., 348, 1625, 10.1056\u002FNEJMoa021423\nSwanson, 1993, Relation of endometrial cancer risk to past and contemporary body size and body fat distribution, Cancer Epidemiol. Biomarkers Prev., 2, 321\nPotischman, 1996, Case-control study of endogenoussteroid hormones and endometrial cancer, J. Natl. Cancer Inst., 88, 1127, 10.1093\u002Fjnci\u002F88.16.1127\nRichelson, 1984, Relative contributions of aging and estrogen deficiency to post-menopausal bone loss, N. Engl. J. Med., 311, 1273, 10.1056\u002FNEJM198411153112002\nKlip, 2000, Cancer risk associated with subfertility and ovulation induction: a review, Cancer Causes Control, 11, 319, 10.1023\u002FA:1008921211309\nLambe, 1999, Childbearing at older age and endometrial cancer risk, Cancer Causes Control, 10, 43, 10.1023\u002FA:1008860615584\nPetrakis, 1987, Influence of pregnancy and lactation on serum and breast fluid estrogen level: implications for breast cancer risk, Int. J. Cancer, 40, 587, 10.1002\u002Fijc.2910400502\nSalerno, 1962, Feminizing mesenchymomas of the ovary: an analysis of 28 granulosa-theca cell tumors and their relationshipto co-existent carcinoma, Am. J. Obstet. Gynecol., 84, 731, 10.1016\u002F0002-9378(62)90022-4\nSpeert, 1949, Endometrial cancer and hepatic cirrhosis, Cancer, 2, 597, 10.1002\u002F1097-0142(194907)2:4\u003C597::AID-CNCR2820020407>3.0.CO;2-0\nDeligeoroglou, 2003, Oral contraceptives and reproductive system cancer, Ann. N. Y. Acad. Sci., 997, 199, 10.1196\u002Fannals.1290.023\n1983, Oral contraceptive use and the risk of endometrial cancer, JAMA, 249, 1600, 10.1001\u002Fjama.1983.03330360040033\nWeiderpass, 1999, Use of oral contraceptives and endometrial cancer risk (Sweden), Cancer Causes Control, 10, 277, 10.1023\u002FA:1008945721786\nLawrence, 1987, Smoking, body weight, and early-stage endometrial cancer, Cancer, 59, 1665, 10.1002\u002F1097-0142(19870501)59:9\u003C1665::AID-CNCR2820590924>3.0.CO;2-2\nHemminki, 2004, Familial clustering of ovarian and endometrial cancers, Eur. J. Cancer, 40, 90, 10.1016\u002FS0959-8049(03)00627-0\nUmar, 2004, Testing guidelines for hereditary non-polyposis colorectal cancer, Nat. Rev. Cancer, 4, 153, 10.1038\u002Fnrc1278\nGehrig, 2004, Association between uterine serous carcinoma and breast cancer, Gynecol. Oncol., 94, 208, 10.1016\u002Fj.ygyno.2004.04.009\nLanger, 1997, Transvaginal ultrasonography comprared with endometrial biopsy for the detection of endometrial disease\u002F Post menopausal estrogen\u002Fprogestin interventions trial, N. Engl. J. Med., 337, 1792, 10.1056\u002FNEJM199712183372502\nRobertson, 2003, Screening for endometrial cancer, Med. J. Aust., 178, 657, 10.5694\u002Fj.1326-5377.2003.tb05400.x\nGerber, 2001, Ultrasonographic detection of asymptomatic endometrial cancer in post menopausal patients offers no pronostic advantage over symptomatic disease discovered by uterine bleeding, Eur. J. Cancer, 37, 64, 10.1016\u002FS0959-8049(00)00356-7\nKim, 1998, Diagnostic and therapeutic advances in gynecology oncology: screening for gynecologic cancer, Cancer Treat. Res., 95, 253, 10.1007\u002F978-1-4615-5447-9_9\nLhomme, 2003, Endometrial surveillance of women on tamoxifen, Gynecol. Obstet. Fertil., 31, 647\nNeven, 1998, Should tamoxifen users be screened for endometrial lesions?, Lancet, 351, 155, 10.1016\u002FS0140-6736(05)78216-7\nLu, 2005, Gynecologic cancer as a \"sentinel cancer\" for women with hereditary non polyposis colorectal cancer syndrome, Obstet. Gynecol., 105, 569, 10.1097\u002F01.AOG.0000154885.44002.ae\nStefansson, 2004, Pronostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type, Histopathology, 44, 472, 10.1111\u002Fj.1365-2559.2004.01882.x\nLax, 2000, A binary architectural grading system for uterine endometrioid carcinoma has superior reproductibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis, Am. J. Surg. Pathol., 24, 1201, 10.1097\u002F00000478-200009000-00002\nZaino, 1988, Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma, Semin. Diagn. Pathol., 5, 154\nSlomovitz, 2003, Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases, Gynecol. Oncol., 91, 463, 10.1016\u002Fj.ygyno.2003.08.018\nWheeler, 2000, Minimal uterine serous carcinoma diagnosis and clinicopathologic correlation, Am. J. Surg. Pathol., 24, 797, 10.1097\u002F00000478-200006000-00004\nGoff, 2005, Uterine papillary serous carcinoma: what have we learned over the past quarter century?, Gynecol. Oncol., 98, 341, 10.1016\u002Fj.ygyno.2005.07.006\nSherman, 1992, Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features, Am. J. Surg. Pathol., 16, 600, 10.1097\u002F00000478-199206000-00008\nAmant, 2005, Endometrial cancer, Lancet, 366, 491, 10.1016\u002FS0140-6736(05)67063-8\nAmbros, 1995, Endometrial intraepithelial carcinoma: a distinctive lesion speciffically associated with tumors displaying serous differentiation, Hum. Pathol., 26, 1260, 10.1016\u002F0046-8177(95)90203-1\nCarcangiu, 1997, Stage IA uterine serous carcinoma: a study of 13 cases, Am. J. Surg. Pathol., 21, 1507, 10.1097\u002F00000478-199712000-00015\nSoslow, 2000, Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis, Am. J. Surg. Pathol., 24, 726, 10.1097\u002F00000478-200005000-00012\nEifel, 1982, Simultaneous presentation of carcinoma involving the ovary and the uterine corpus, Cancer, 50, 163, 10.1002\u002F1097-0142(19820701)50:1\u003C163::AID-CNCR2820500131>3.0.CO;2-K\nBrinkmann, 2004, A molecular genetic and statistical approach for the diagnosisof dual-site cancers, J. Natl. Cancer Inst., 96, 1441, 10.1093\u002Fjnci\u002Fdjh272\nBokhman, 1983, Two pathogenetic types of endometrial carcinoma, Gynecol. Oncol., 15, 10, 10.1016\u002F0090-8258(83)90111-7\nGupta, 2002, Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis, Acta Obstet. Gynecol. Scand., 81, 799, 10.1034\u002Fj.1600-0412.2001.810902.x\nSmith-Bindman, 1998, Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities, JAMA, 280, 1510, 10.1001\u002Fjama.280.17.1510\nTabor, 2002, Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding, Obstet. Gynecol., 99, 663\nTrimble, 2005, Atypical endometrial hyperplasia: a tough call, Int. J. Gynecol. Cancer, 15, 401, 10.1111\u002Fj.1525-1438.2005.t01-1-abst_5.x\nEddy, 1997, Papanicolaou smears by the Bethesda system in endometrial malignancy: utility and pronostic importance, Obstet. Gynecol., 90, 999, 10.1016\u002FS0029-7844(97)00548-6\nFukuda, 1999, Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance, Gynecol. Oncol., 72, 273, 10.1006\u002Fgyno.1998.5244\nLarson, 1994, Pronostic significance of malignant cervical cytology in patient with endometrial cancer, Obstet. Gynecol., 84, 399\nGoff, 1994, Surgical stage IV endometrial carcinoma: a study of 47 cases, Gynecol. Oncol., 52, 237, 10.1006\u002Fgyno.1994.1038\nHricak, 1987, Endometrial carcinoma staging by MR imaging, Radiology, 162, 297, 10.1148\u002Fradiology.162.2.3797641\nDubinsky, 1997, The role of transvaginal sonography and endometrial biopsy in the evaluation of peri and postmenopausal bleeding, Am. J. Roentgenol., 169, 145, 10.2214\u002Fajr.169.1.9207515\nGoldstein, 2001, Evaluation of the woman with postmenopausal bleeding: Society of Radiologists in Ultrasound-Sponsored Concensus Conference statement, J. Ultrasound. Med., 20, 1025, 10.7863\u002Fjum.2001.20.10.1025\nGull, 2003, Can ultrasound replace dilatation and curettag? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer, Am. J. Obstet. Gynecol., 188, 401, 10.1067\u002Fmob.2003.154\nGrasel, 2000, Endometrial polyps: MR imaging features and distinction from endometrial carcinoma, Radiology, 214, 47, 10.1148\u002Fradiology.214.1.r00ja3647\nWeber, 1997, Vaginal ultrasonography versus endometrial biopsy in women with postmenopausal bleeding, Am. J. Obstet. Gynecol., 177, 924, 10.1016\u002FS0002-9378(97)70295-3\nFerrazzi, 1996, Sonographic endometrial thickness: a useful test to predict atrophy in patients with post menopausal bleeding. An italian multicenter study, Ultrasound Obstet. Gynecol., 7, 315, 10.1046\u002Fj.1469-0705.1996.07050315.x\nDijkhuizen, 2000, The accuracy of endometrial sampling in the diagnosis of patients with endometrial cancer: a systematic quantitative review, Cancer, 89, 1765, 10.1002\u002F1097-0142(20001015)89:8\u003C1765::AID-CNCR17>3.0.CO;2-F\nKarlsson, 1995, Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: A Nordic Multicenter Study, Am. J. Obstet. Gynecol., 172, 1488, 10.1016\u002F0002-9378(95)90483-2\nPhillip, 2004, Correlation between transvaginal ultrasound measured endometrial thickness and histopathologic findings in Afro-Carrbean Jamaican women with postmenopausal bleeding, J. Obstet. Gynecol., 24, 568, 10.1080\u002F01443610410001722671\nvan Doorn, 2004, Accuracy of transvaginal ultrasonography in diabetic or obese women with post menopausal bleeding, Obstet. Gynecol., 104, 571, 10.1097\u002F01.AOG.0000136080.55874.7f\nWang, 2006, Thin endometrial echo complex on ultrasound does not reliably exclude type 2 endometrial cancers, Gynecol. Oncol., 101, 120, 10.1016\u002Fj.ygyno.2005.09.042\nSchwarzler, 1998, An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology, Ultrasound Obstet. Gynecol., 11, 337, 10.1046\u002Fj.1469-0705.1998.11050337.x\nGoldstein, 1997, Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding, Am. J. Obstet. Gynecol., 177, 102, 10.1016\u002FS0002-9378(97)70446-0\nAyhan, 1994, Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases), Int. J. Gynecol. Cancer, 4, 306, 10.1046\u002Fj.1525-1438.1994.04050306.x\nBradley, 2004, Hysteroscopy and cytology in endometrial cancer, Obstet. Gynecol., 104, 1030, 10.1097\u002F01.AOG.0000143263.19732.18\nNarducci, 2006, What is new in the surgical treatment of pelvic gynecologic cancers?, Bull. Cancer, 93, 43\nDessole, 2006, Risks and usefulness of sonohysterography in patients with endometrial carcinoma, Am. J. Obstet. Gynecol., 194, 362, 10.1016\u002Fj.ajog.2005.08.036\nValenzano, 2001, The role of transvaginal ultrasound and sonohysterography in the diagnosis and staging of endometrial adenocarcinoma, Radiol. Med. (Torino), 101, 365\nClark, 2002, Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review, BJOG, 109, 313, 10.1111\u002Fj.1471-0528.2002.01088.x\nKoss, 1981, Screening of asymptomatic women for endometrial cancer, Obstet. Gynecol., 57, 681\nGarcia, 2003, Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding, J. Reprod. Med., 48, 882\nEpstein, 2001, Dilatation and curettage fails to detect most focal lésions in the uterine cavity in women with post menopausal bleeding, Acta Obstet. Gynecol. Scand., 80, 1121, 10.1034\u002Fj.1600-0412.2001.801210.x\nObermair, 1999, Endometrial cancer accuracy of the finding of a well-differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy, Int. J. Gynecol. Cancer, 9, 383, 10.1046\u002Fj.1525-1438.1999.99050.x\nDaniel, 1988, Accuracy of office and operating room curretage in the grading of endometrial carcininoma, Obstet. Gynecol., 71, 612\nDijkhuizen, 2003, Cost-effectiveness of the use of transvaginal sonography in the evaluation of post menopausal bleeding, Maturitas, 45, 275, 10.1016\u002FS0378-5122(03)00152-X\nClark, 2006, Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies, BJOG, 113, 502, 10.1111\u002Fj.1471-0528.2006.00914.x\nCreasman, 1989, FIGO stage 1988 revision, Gynecol. Oncol., 35, 125\nCreutzberg, 2000, Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma, Lancet, 355, 1404, 10.1016\u002FS0140-6736(00)02139-5\nZuurendonk, 2006, Routine pelvic lymphadenectomy in apparently early stage endometrial cancer, Eur. J. Surg. Oncol., 32, 450, 10.1016\u002Fj.ejso.2006.02.008\nKinkel, 1999, Radiologic staging in patients with endometrial cancer: a meta-analysis, Radiology, 212, 711, 10.1148\u002Fradiology.212.3.r99au29711\nBoronow, 1984, Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study, Obstet. Gynecol., 63, 825\nCreasman, 1987, Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study, Cancer, 60, 2035, 10.1002\u002F1097-0142(19901015)60:8+\u003C2035::AID-CNCR2820601515>3.0.CO;2-8\nPiver, 1982, Paraaortic lymph node evaluation in stage I endometrial carcinoma, Obstet. Gynecol., 59, 97\nSironi, 1992, Myometrialinvasion by endometrial carcinoma: assessment with plain and galodinium-enhanced MR imaging, Radiology, 185, 207, 10.1148\u002Fradiology.185.1.1523309\nGoff, 1990, Assessment of depth of myometrial invasion in endometrial adenocarcinoma, Gynecol. Oncol., 38, 46, 10.1016\u002F0090-8258(90)90009-A\nDoering, 1989, Intraoperative evaluation of depth of myometrial invasion in stage I endometrial adenocarcinoma, Obstet. Gynecol., 74, 930\nQuinlivan, 2001, Accuracy of frozen section for the operative management of endometrial cancer, BJOG, 108, 798\nFrumovitz, 2004, Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer, J. Am. Coll. Surg., 199, 388, 10.1016\u002Fj.jamcollsurg.2004.05.258\nOlaya, 1998, Transvaginal sonography in endometrial carcinoma: preoperative assessment of the depth of myometrial invasion in 50 cases, Eur. J. Radiol., 26, 274, 10.1016\u002FS0720-048X(96)01129-1\nTeefey, 1996, Local staging of endometrial carcinoma:comparison of transvaginal and intraoperative sonography and gross visual inspection, AJR Am. J. Roentgenol., 166, 547, 10.2214\u002Fajr.166.3.8623626\nYamashita, 1993, Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging, AJR Am. J. Roentgenol., 161, 595, 10.2214\u002Fajr.161.3.8352114\nBalfe, 1983, Computed tomography in malignant endometrial neoplasms, J. Comput. Assist. Tomogr., 7, 677, 10.1097\u002F00004728-198308000-00018\nDore, 1987, CT evaluation of myometrium invasion in endometrial carcinoma, J. Comput. Assist. Tomogr., 11, 282, 10.1097\u002F00004728-198703000-00018\nKim, 1995, Detection of deep myometrial invasion in endometrial carcinoma:comparison of transvaginal ultrasound, CT, and MRI, J. Comput. Assist. Tomogr., 19, 766, 10.1097\u002F00004728-199509000-00013\nWalsh, 1982, Computed tomography of primary persistent, and recurrent endometrial malignancy, Am. J. Roentgenol., 139, 1149, 10.2214\u002Fajr.139.6.1149\nConnor, 2000, Computed tomography in endometrial carcinoma, Obstet. Gynecol., 95, 692\nJoja, 1996, Endometrial carcinoma: dynamic MRI with turbo-FLASH technique, J. Comput. Assist. Tomogr., 20, 878, 10.1097\u002F00004728-199611000-00003\nManfredi, 2005, Endometrial cancer: magnetic resonance imaging, Abdom. Imaging, 30, 626, 10.1007\u002Fs00261-004-0298-9\nSavci, 1998, Assessment of depth of myometrial carcinoma:comparison of T2-weighted SE and contrast-enhanced dynamic GRE MR imaging, Eur. Radiol., 8, 218, 10.1007\u002Fs003300050365\nIto, 2004, Endometrial cancer diagnosis by MR imaging, Nippon Rinsho, 62, 313\nSeki, 2000, Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix, Am. J. Roentgenol., 175, 171, 10.2214\u002Fajr.175.1.1750171\nToki, 1998, A comparative study of pre-operative procedures to assess cervical invasion by endometril carcinoma, Br. J. Obstet. Gynaecol., 105, 512, 10.1111\u002Fj.1471-0528.1998.tb10151.x\nBurghardt, 1978, Local spread and lymph node involvement in cervical cancer, Obstet. Gynecol., 52, 138\nTrattner, 2001, Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume, Gynecol. Oncol., 82, 11, 10.1006\u002Fgyno.2001.6252\nMeroni, 2004, T2 weighted MRI in the pre-operative assessment of myometrial and cervical invasions in endometrial carcinoma, Br J Radiol Congress Series, 30, 6\nO'Connel, 1998, Triage of abnormal postmenopausal bleeding: a comparaison of endometrial biopsy and transvaginal sonohysterography versus fractional curettage with hysteroscopy, Am. J. Obstet. Gynecol., 178, 956, 10.1016\u002FS0002-9378(98)70530-7\nKim, 1994, Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging, Radiology, 190, 807, 10.1148\u002Fradiology.190.3.8115631\nBipat, 2003, Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review, Gynecol. Oncol., 91, 59, 10.1016\u002FS0090-8258(03)00409-8\nRockall, 2005, Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer, J. Clin. Oncol., 23, 2813, 10.1200\u002FJCO.2005.07.166\nManfredi, 2004, Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning, Radiology, 231, 372, 10.1148\u002Fradiol.2312021184\nAscher, 2002, Imaging of cancer of the endometrium, Radiol. Clin. North Am., 40, 563, 10.1016\u002FS0033-8389(01)00013-6\nBerman, 1980, Prognosis and treatment of endometrial cancer, Am. J. Obstet. Gynecol., 136, 679, 10.1016\u002F0002-9378(80)91024-8\nChao, 2006, 18F-FDG PET in the management of endometrial cancer, Eur. J. Nucl. Med. Mol. Imaging, 33, 36, 10.1007\u002Fs00259-005-1876-y\nHorowitz, 2004, Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer, Gynecol. Oncol., 95, 546, 10.1016\u002Fj.ygyno.2004.08.009\nSood, 1997, Value of preoperative CA125 level in the management of uterine cancer and prediction of clinical outcome, Obstet. Gynecol., 90, 441, 10.1016\u002FS0029-7844(97)00286-X\nDotters, 2000, Preoperative CA125 in endometrial cancer: is it useful?, Am. J. Obstet. Gynecol., 182, 1328, 10.1067\u002Fmob.2000.106251\nMorrow, 1991, Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study, Gynecol. Oncol., 40, 55, 10.1016\u002F0090-8258(91)90086-K\nCreasman, 1981, Pronostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals, Am. J. Obstet. Gynecol., 141, 921, 10.1016\u002FS0002-9378(16)32684-9\nSaga, 2006, Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus?, Gynecol. Oncol., 103, 277, 10.1016\u002Fj.ygyno.2006.03.003\nTurner, 1989, The pronostic significance of peritonel cytology for stage I endometrial cancer, Obstet. Gynecol., 74, 775\nObermair, 2000, Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioïd adenocarcinoma of the uterus, Cancer Lett., 164, 105, 10.1016\u002FS0304-3835(00)00722-9\nKasamatsu, 2003, Pronostic significance of peritoneal cytology in endometrial carcinoma confined to the uterus, Br. J. Cancer, 88, 245, 10.1038\u002Fsj.bjc.6600698\nTebeu, 2004, Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis, Br. J. Cancer, 91, 720, 10.1038\u002Fsj.bjc.6602035",{"ES":931},"Cáncer de endometrio",{"VOID":933},"10.1016\u002Fs1283-081x(09)70794-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X09707945",[936,951,966,981],{"id":937,"sortIndex":59,"researcher":26,"roles":938,"affiliations":939,"properties":948},"cef910cc-fa95-4bae-8172-8046433edf2f",[696],[940],{"id":26,"sortIndex":36,"affiliation":941,"properties":26},{"id":942,"createTime":943,"updateTime":943,"relativeEntities":944,"slug":26,"properties":945,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"790aef77-2587-4290-96a5-b3728d6154d7","2023-12-28T21:25:20.452+00:00",[],{"title":946},{"VI":947},"Service d'anatomie pathologique, Hôpital Jeanne de Flandre, Centre hospitalier régional universitaire de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France",{"title":949},{"VI":950},"M.-O. Farine",{"id":952,"sortIndex":114,"researcher":26,"roles":953,"affiliations":954,"properties":963},"d31b973b-ee99-47cf-ae97-31689369e959",[696],[955],{"id":26,"sortIndex":36,"affiliation":956,"properties":26},{"id":957,"createTime":958,"updateTime":958,"relativeEntities":959,"slug":26,"properties":960,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"cecee8a2-37a4-4d94-9091-7ab927f86a9f","2023-12-28T21:25:20.437+00:00",[],{"title":961},{"VI":962},"Service de radiologie, Hôpital Jeanne de Flandre, Centre hospitalier régional universitaire de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France",{"title":964},{"VI":965},"E. Poncelet",{"id":967,"sortIndex":115,"researcher":26,"roles":968,"affiliations":969,"properties":978},"84006b33-c306-4c93-9b75-ac620154bf45",[696],[970],{"id":26,"sortIndex":36,"affiliation":971,"properties":26},{"id":972,"createTime":973,"updateTime":973,"relativeEntities":974,"slug":26,"properties":975,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6c25f16e-a544-4f68-9f28-7f0cc22dbc6a","2023-12-28T21:25:20.402+00:00",[],{"title":976},{"VI":977},"Service de chirurgie gynécologique, Hôpital Jeanne de Flandre, Centre hospitalier régional universitaire de Lille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France",{"title":979},{"VI":980},"P. Collinet",{"id":982,"sortIndex":36,"researcher":26,"roles":983,"affiliations":984,"properties":990},"4789b1fe-417d-4eb8-a059-6833ff9b4245",[696],[985],{"id":26,"sortIndex":36,"affiliation":986,"properties":26},{"id":972,"createTime":973,"updateTime":973,"relativeEntities":987,"slug":26,"properties":988,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":989},{"VI":977},{"title":991},{"VI":992},"D. Vinatier",{"url":934,"publisher":994,"properties":1002},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":995,"slug":662,"properties":996,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":999,"manageAffiliations":1000,"indexDatabases":1001,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":997,"title":998},{"VOID":665},{"EN":667},[],[],[],{"volume":1003,"pages":1005},{"VOID":1004},"45",{"VOID":1006},"1-13","2009-01-01",2009,{"id":1010,"createTime":1011,"updateTime":1011,"relativeEntities":1012,"slug":26,"properties":1013,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":114,"primaryUrl":1020,"fullTextUrl":26,"authors":1021,"publicationType":747,"publisherRelationship":1052,"citationCount":26,"citationInfo":26,"publishDate":1066,"publishYear":1067,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a68a040f-32ab-42ef-bdcc-ef11a2297f4c","2024-01-01T11:55:46.467+00:00",[],{"references":1014,"title":1016,"doi":1018},{"VOID":1015},"Schmorl, 1893\nWalknowska, 1969, Practical and theoretical implications of fetal-maternal lymphocyte transfer, Lancet, 1, 1119, 10.1016\u002FS0140-6736(69)91642-0\nHo, 2003, Fetal cells in maternal blood: state of the art for non-invasive prenatal diagnosis, Ann. Acad. Med. Singapore, 32, 597\nOudejans, 2003, Circulating trophoblast in maternal blood, Prenat. Diagn., 23, 111, 10.1002\u002Fpd.539\nWesterman, 2001, The human achaete scute homolog 2 gene contains two promotors, generating overlapping transcripts and encoding two proteins with different nuclear localization, Placenta, 22, 511, 10.1053\u002Fplac.2001.0695\nKirszenbaum, 1994, An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes, Proc. Natl. Acad. Sci. USA, 91, 4209, 10.1073\u002Fpnas.91.10.4209\nvan Wijk, 2001, HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy, Am. J. Obstet. Gynecol., 184, 991, 10.1067\u002Fmob.2001.112973\nVona, 2002, Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood, Am. J. Pathol., 160, 51, 10.1016\u002FS0002-9440(10)64348-9\nBianchi, 1996, Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum, Proc. Natl. Acad. Sci. USA, 93, 705, 10.1073\u002Fpnas.93.2.705\nLo, 1994, Culture of fetal erythroid cells from maternal peripheral blood, Lancet, 344, 264, 10.1016\u002FS0140-6736(94)93031-7\nValerio, 1996, Culture of fetal erythroid progenitor cells from maternal blood for non-invasive prenatal genetic diagnosis, Prenat. Diagn., 16, 1073, 10.1002\u002F(SICI)1097-0223(199612)16:12\u003C1073::AID-PD38>3.0.CO;2-D\nCampagnoli, 2001, Identification of mesenchymal stem\u002Fprogenitor cells in human first-trimester fetal blood, liver, and bone marrow, Blood, 98, 2396, 10.1182\u002Fblood.V98.8.2396\nO'Donoghue, 2003, Identification of fetal mesenchymal stem cells in maternal blood: implications for non-invasive prenatal diagnosis, Mol. Hum. Reprod., 9, 497, 10.1093\u002Fmolehr\u002Fgag063\nSrivatsa, 2001, Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study, Lancet, 358, 2034, 10.1016\u002FS0140-6736(01)07099-4\nO'Donoghue, 2004, Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy, Lancet, 364, 179, 10.1016\u002FS0140-6736(04)16631-2\nShulman, 2003, Fetal cells in maternal blood, Curr. Womens Health Rep., 3, 47\nChoolani, 2001, Simultaneous fetal cell identification and diagnosis by epsilon-globin chain immunophenotyping and chromosomal fluorescence in situ hybridization, Blood, 98, 554, 10.1182\u002Fblood.V98.3.554\nKrabchi, 2001, Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques, Clin. Genet., 60, 145, 10.1034\u002Fj.1399-0004.2001.600209.x\nBianchi, 1997, PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies, Am. J. Hum. Genet., 61, 822, 10.1086\u002F514885\nGuibert, 2003, Kinetics of SRY gene appearance in maternal serum: detection by real time PCR in early pregnancy after assisted reproductive technique, Hum. Reprod., 18, 1733, 10.1093\u002Fhumrep\u002Fdeg320\nAriga, 2001, Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis, Transfusion, 41, 1524, 10.1046\u002Fj.1537-2995.2001.41121524.x\nHerzenberg, 1979, Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting, Proc. Natl. Acad. Sci. USA, 76, 1453, 10.1073\u002Fpnas.76.3.1453\nWang, 2000, Fetal nucleated erythrocyte recovery: fluorescence activated cell sorting-based positive selection using anti-gamma globin versus magnetic activated cell sorting using anti-CD45 depletion and anti-gamma globin positive selection, Cytometry, 39, 224, 10.1002\u002F(SICI)1097-0320(20000301)39:3\u003C224::AID-CYTO8>3.0.CO;2-J\nZheng, 1993, Prenatal diagnosis from maternal blood: simultaneous immunophenotyping and FISH of fetal nucleated erythrocytes isolated by negative magnetic cell sorting, J. Med. Genet., 30, 1051, 10.1136\u002Fjmg.30.12.1051\nCheung, 1996, Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood, Nat. Genet., 14, 264, 10.1038\u002Fng1196-264\nCamaschella, 1990, Prenatal diagnosis of fetal hemoglobin Lepore-Boston disease on maternal peripheral blood, Blood, 75, 2102, 10.1182\u002Fblood.V75.11.2102.2102\nSekizawa, 1996, Prenatal diagnosis of Duchenne muscular dystrophy using a single fetal nucleated erythrocyte in maternal blood, Neurol., 46, 1350, 10.1212\u002FWNL.46.5.1350\nBeroud, 2003, Prenatal diagnosis of spinal muscular atrophy by genetic analysis of circulating fetal cells, Lancet, 361, 1013, 10.1016\u002FS0140-6736(03)12798-5\nWatanabe, 1998, Prenatal diagnosis of ornithine transcarbamylase deficiency by using a single nucleated erythrocyte from maternal blood, Hum. Genet., 102, 611, 10.1007\u002Fs004390050750\nBianchi, 2002, Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data, Prenat. Diagn., 22, 609, 10.1002\u002Fpd.347\nSekizawa, 2000, Apoptosis in fetal nucleated erythrocytes circulating in maternal blood, Prenat. Diagn., 20, 886, 10.1002\u002F1097-0223(200011)20:11\u003C886::AID-PD942>3.0.CO;2-4\nZhong, 2002, Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts, Mol. Hum. Reprod., 8, 864, 10.1093\u002Fmolehr\u002F8.9.864\nZhong, 2000, Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma, Obstet. Gynecol., 96, 991, 10.1016\u002FS0029-7844(00)01065-6\nLo, 1998, Quantitative analysis of foetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis, Am. J. Hum. Genet., 62, 768, 10.1086\u002F301800\nHonda, 2002, Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum, Hum. Genet., 110, 75, 10.1007\u002Fs00439-001-0649-3\nChan, 2003, Serial analysis of fetal DNA concentrations in maternal plasma in late pregnancy, Clin. Chem., 49, 678, 10.1373\u002F49.4.678\nOhashi, 2002, Correlation of fetal DNA and human chorionic gonadotropin concentrations in second-trimester maternal serum, Clin. Chem., 48, 386, 10.1093\u002Fclinchem\u002F48.2.386\nFlori, 2004, Circulating cell-free fetal DNA in maternal serum likely originates from cyto- and syncytio-trophoblastic cells, Hum. Reprod., 19, 723, 10.1093\u002Fhumrep\u002Fdeh117\nGuibert, 2003, Kinetics of SRY gene appearance in maternal serum: detection by real-time PCR in early pregnancy after assisted reproductive technique, Hum. Reprod., 18, 1733, 10.1093\u002Fhumrep\u002Fdeg320\nBianchi, 2001, Large amounts of cell-free fetal DNA are present in amniotic fluid, Clin. Chem., 47, 1867, 10.1093\u002Fclinchem\u002F47.10.1867\nAngert, 2004, Cell-free fetal DNA in the cerebrospinal fluid of women during the peripartum period, Am. J. Obstet. Gynecol., 190, 1087, 10.1016\u002Fj.ajog.2003.10.562\nCioni, 2003, Detection of fetal DNA in the peritoneal cavity during pregnancy, Eur. J. Obstet. Gynecol. Reprod. Biol., 107, 210, 10.1016\u002FS0301-2115(02)00262-2\nAl-Yatama, 2001, Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction, Prenat. Diagn., 21, 399, 10.1002\u002Fpd.69\nLo, 1999, Rapid clearance of foetal DNA from maternal plasma, Am. J. Hum. Genet., 64, 218, 10.1086\u002F302205\nWataganara, 2004, Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy, Fertil. Steril., 81, 638, 10.1016\u002Fj.fertnstert.2003.07.028\nInvernizzi, 2002, Presence of fetal DNA in maternal plasma decades after pregnancy, Hum. Genet., 110, 587, 10.1007\u002Fs00439-002-0725-3\nSekizawa, 2001, Accuracy of fetal gender determination by analysis of DNA in maternal plasma, Clin. Chem., 47, 1856, 10.1093\u002Fclinchem\u002F47.10.1856\nCosta, 2001, First trimester fetal sex determination in maternal serum using a real-time PCR, Prenat. Diagn., 21, 1070, 10.1002\u002Fpd.219\nFinning, 2002, Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service, Transfusion, 42, 1079, 10.1046\u002Fj.1537-2995.2002.00165.x\nCosta, 2002, Fetal RHD genotyping in maternal serum during the first trimester of pregnancy, Br. J. Haematol., 119, 255, 10.1046\u002Fj.1365-2141.2002.03780.x\nSmid, 2003, No evidence of fetal DNA persistence in maternal plasma after pregnancy, Hum. Genet., 112, 617, 10.1007\u002Fs00439-003-0919-3\nBenachi, 2003, Fetal DNA in maternal serum: does it persist after pregnancy?, Hum. Genet., 113, 76, 10.1007\u002Fs00439-003-0931-7\nMielke, 1998, Foetal sex determination by high resolution in early pregnancy, Eur. J. Ultrasound, 7, 109, 10.1016\u002FS0929-8266(98)00014-7\nEfrat, 1999, First-trimester determination of foetal gender by ultrasound, Ultrasound Obstet. Gynecol., 13, 305, 10.1046\u002Fj.1469-0705.1999.13050305.x\nCosta, 2002, A new strategy of prenatal diagnosis in X-linked disorders, N. Engl. J. Med., 346, 1502, 10.1056\u002FNEJM200205093461918\nRijnders, 2001, Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia, Obstet. Gynecol., 98, 374, 10.1016\u002FS0029-7844(01)01480-6\nBartha, 2003, Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency, Obstet. Gynecol., 101, 1135, 10.1016\u002FS0029-7844(03)00064-4\nLo, 1998, Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N. Engl. J. Med., 339, 1734, 10.1056\u002FNEJM199812103392402\nZhang, 2000, Determination of foetal RHD status by maternal plasma DNA analysis, Ann. N. Y. Acad. Sci., 906, 153, 10.1111\u002Fj.1749-6632.2000.tb06606.x\nWagner, 2001, RHD positive haplotypes in D negative Europeans, BMC Genet., 2, 10, 10.1186\u002F1471-2156-2-10\nRouillac-Le Sciellour, 2004, Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women, Mol. Diagn., 8, 23, 10.2165\u002F00066982-200408010-00004\nAmicucci, 2000, Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma, Clin. Chem., 46, 301, 10.1093\u002Fclinchem\u002F46.2.301\nChen, 2000, Fetal DNA in maternal plasma: the prenatal detection of a paternally inherited fetal aneuploidy, Prenat. Diagn., 20, 355, 10.1002\u002F(SICI)1097-0223(200004)20:4\u003C355::AID-PD800>3.0.CO;2-#\nFucharoen, 2003, Prenatal detection of fetal hemoglobin E gene from maternal plasma, Prenat. Diagn., 23, 393, 10.1002\u002Fpd.607\nGonzalez-Gonzalez, 2003, Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR, Prenat. Diagn., 23, 232, 10.1002\u002Fpd.570\nPertl, 2000, Detection of male and female DNA in maternal plasma by multiplex fluorescent polymerase chain reaction amplification of short tandem repeats, Hum. Genet., 106, 45, 10.1007\u002Fs004390051008\nGonzalez-Gonzalez, 2002, Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma, Prenat. Diagn., 22, 946, 10.1002\u002Fpd.439\nNasis, 2004, Improvement in sensitivity of allele-specific PCR facilitates reliable noninvasive prenatal detection of cystic fibrosis, Clin. Chem., 50, 694, 10.1373\u002Fclinchem.2003.025981\nChiu, 2002, Prenatal exclusion of beta thalassemia major by examination of maternal plasma, Lancet, 360, 998, 10.1016\u002FS0140-6736(02)11086-5\nChiu, 2002, Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study, Clin. Chem., 48, 778, 10.1093\u002Fclinchem\u002F48.5.778\nSaito, 2000, Prenatal DNA diagnosis of a single-gene disorder from maternal plasma, Lancet, 356, 1170, 10.1016\u002FS0140-6736(00)02767-7\nPoon, 2002, Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma, Clin. Chem., 48, 35, 10.1093\u002Fclinchem\u002F48.1.35\nZhong, 2001, Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia, Am. J. Obstet. Gynecol., 184, 414, 10.1067\u002Fmob.2001.109594\nLeung, 1998, Maternal plasma fetal DNA as a marker for preterm labour, Lancet, 352, 1904, 10.1016\u002FS0140-6736(05)60395-9\nLau, 2000, Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term, Am. J. Obstet. Gynecol., 183, 712, 10.1067\u002Fmob.2000.106582\nZhong, 2000, High levels of fetal erythroblasts and fetal extracellular DNA in the peripheral blood of a pregnant women with idiopathic polyhydramnios: case report, Prenat. Diagn., 20, 838, 10.1002\u002F1097-0223(200010)20:10\u003C838::AID-PD911>3.0.CO;2-P\nSugito, 2003, Relation between severity of hyperemesis gravidum and fetal DNA concentration in maternal plasma, Clin. Chem., 49, 1667, 10.1373\u002F49.10.1667\nZhong, 2000, Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses, Prenat. Diagn., 20, 795, 10.1002\u002F1097-0223(200010)20:10\u003C795::AID-PD897>3.0.CO;2-P\nOhashi, 2001, Quantitation of fetal DNA in maternal serum in normal and aneuploid pregnancies, Hum. Genet., 108, 123, 10.1007\u002Fs004390100457\nJohnson, 2004, Interlaboratory comparison of fetal male DNA detection from common maternal plasma by real-time PCR, Clin. Chem., 50, 516, 10.1373\u002Fclinchem.2003.024380\nCosta, 2002, Automated assay for fetal DNA analysis in maternal serum, Clin. Chem., 48, 679, 10.1093\u002Fclinchem\u002F48.4.679\nPoon, 2000, Presence of fetal RNA in maternal plasma, Clin. Chem., 46, 1832, 10.1093\u002Fclinchem\u002F46.11.1832\nCosta, 2003, Fetal expressed gene analysis in maternal blood: a new tool for noninvasive study of the fetus, Clin. Chem., 49, 981, 10.1373\u002F49.6.981\nNg, 2003, mRNA of placental origin is readily detectable in maternal plasma, Proc. Natl. Acad. Sci. USA, 100, 4748, 10.1073\u002Fpnas.0637450100\nGo, 2004, Detection of placental transcription factor mRNA in maternal plasma, Clin. Chem., 50, 1413, 10.1373\u002Fclinchem.2004.032979",{"ES":1017},"Diagnóstico prenatal mediante muestra de sangre materna",{"VOID":1019},"10.1016\u002Fs1283-081x(05)44255-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X05442551",[1022,1037],{"id":1023,"sortIndex":36,"researcher":26,"roles":1024,"affiliations":1025,"properties":1034},"ff328c25-2603-48b3-baa3-5549a4d470b4",[696],[1026],{"id":26,"sortIndex":36,"affiliation":1027,"properties":26},{"id":1028,"createTime":1029,"updateTime":1029,"relativeEntities":1030,"slug":26,"properties":1031,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"ba178108-6cb8-4044-858e-e8f4c055a995","2024-01-09T13:44:32.656+00:00",[],{"title":1032},{"VI":1033},"Laboratoire de biologie moléculaire, Centre de diagnostic prénatal, Hôpital américain de Paris, 63, boulevard Victor-Hugo, 92200 Neuilly-sur-Seine, France",{"title":1035},{"VI":1036},"J.-M. Costa",{"id":1038,"sortIndex":115,"researcher":26,"roles":1039,"affiliations":1040,"properties":1049},"b163b2d9-c3f9-4ad1-9ad0-8ecdf2b20f73",[696],[1041],{"id":26,"sortIndex":36,"affiliation":1042,"properties":26},{"id":1043,"createTime":1044,"updateTime":1044,"relativeEntities":1045,"slug":26,"properties":1046,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"22241238-5f14-48f8-9601-6986e63b760d","2024-01-01T11:55:46.479+00:00",[],{"title":1047},{"VI":1048},"Maternité, Hôpital Necker-Enfants Malades, Centre de Diagnostic Prénatal, Université Paris V",{"title":1050},{"VI":1051},"A. Benachi",{"url":1020,"publisher":1053,"properties":1061},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1054,"slug":662,"properties":1055,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1058,"manageAffiliations":1059,"indexDatabases":1060,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1056,"title":1057},{"VOID":665},{"EN":667},[],[],[],{"volume":1062,"pages":1064},{"VOID":1063},"41",{"VOID":1065},"1-8","2005-01-01",2005,{"id":1069,"createTime":1070,"updateTime":1070,"relativeEntities":1071,"slug":26,"properties":1072,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1079,"fullTextUrl":26,"authors":1080,"publicationType":747,"publisherRelationship":1111,"citationCount":26,"citationInfo":26,"publishDate":1007,"publishYear":1008,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4be36ad3-7ee1-4f0c-be55-a527cfea15de","2024-01-19T07:12:19.871+00:00",[],{"references":1073,"title":1075,"doi":1077},{"VOID":1074},"Nicolaides, 1992, Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy, BMJ, 304, 867, 10.1136\u002Fbmj.304.6831.867\nSnijders, 1998, UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation, Lancet, 351, 343, 10.1016\u002FS0140-6736(97)11280-6\nNicolaides, 1999\nSureau C, Henrion R. Rapport du Comité national technique de l'échographie de dépistage prénatal. Avril 2005. http:\u002F\u002Fwww.orpha.net\u002Facta\u002Forpahnews\u002F2005\u002Fdoc.echofoetale.pdf.\nNicolaides, 2004, Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities, Am. J. Obstet. Gynecol., 191, 45, 10.1016\u002Fj.ajog.2004.03.090\nBindra, 2002, Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks, Clin. Obstet. Gynecol., 45, 661, 10.1097\u002F00003081-200209000-00010\nSnijders, 2002, The role of fetal nuchal translucency in prenatal screening, Curr. Opin. Obstet. Gynecol., 14, 577, 10.1097\u002F00001703-200212000-00002\nSouka, 1998, Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation, Ultrasound Obstet. Gynecol., 11, 391, 10.1046\u002Fj.1469-0705.1998.11060391.x\nSouka, 2005, Increased nuchal translucency with normal karyotype, Am. J. Obstet. Gynecol., 192, 1005, 10.1016\u002Fj.ajog.2004.12.093\nHaak, 2003, Pathophysiology of increased nuchal translucency: a review of the literature, Hum. Reprod. Update, 9, 175, 10.1093\u002Fhumupd\u002Fdmg008\nDucarme, 2005, Hyperclarté nucale et hygroma cervical au premier trimestre de la grossesse : diagnostic prénatal et devenir néonatal, Gynecol. Obstet. Fertil., 33, 750, 10.1016\u002Fj.gyobfe.2005.07.031\nSouka, 2001, Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester, Ultrasound Obstet. Gynecol., 18, 9, 10.1046\u002Fj.1469-0705.2001.00454.x\nBilardo, 2007, Increased nuchal translucency thickness and normal karyotypes: time for parental reassurance, Ultrasound Obstet. Gynecol., 30, 11, 10.1002\u002Fuog.4044\nSenat, 2007, Hyperclarté nucale à caryotype normal, Gynecol. Obstet. Fertil., 35, 507, 10.1016\u002Fj.gyobfe.2007.03.012\nVan Vugt, 1998, Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation, Ultrasound Obstet. Gynecol., 11, 407, 10.1046\u002Fj.1469-0705.1998.11060407.x\nAdekunle, 1999, Increased first-trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected population, Br. J. Radiol., 72, 457, 10.1259\u002Fbjr.72.857.10505009\nMaymon, 2000, Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency, Hum. Reprod., 15, 2023, 10.1093\u002Fhumrep\u002F15.9.2023\nBrady, 1998, Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation, J. Med. Genet., 35, 222, 10.1136\u002Fjmg.35.3.222\nHippala, 2001, Fetal nuchal translucency and normal chromosomes: a long-term follow-up study, Ultrasound Obstet. Gynecol., 18, 18, 10.1046\u002Fj.1469-0705.2001.00481.x\nSenat, 2002, Pregnancy outcome in fetuses with increased nuchal translucency and normal caryotype, Prenat. Diagn., 22, 345, 10.1002\u002Fpd.321\nCheng, 2004, Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening, Int. J. Gynaecol. Obstet., 84, 5, 10.1016\u002FS0020-7292(03)00206-6\nSenat, 2007, Long term outcome of children born after a first trimester measurement of nuchal translucency ≥ 99th percentile with normal karyotypes, Am J Obstet Gynecol, 196, 53.e1, 10.1016\u002Fj.ajog.2006.08.026\nWhitlow, 1998, The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester, Ultrasound Obstet. Gynecol., 11, 258, 10.1046\u002Fj.1469-0705.1998.11040258.x\nBraithwaite, 1995, The measurement of nuchal translucency with transabdominal and transvaginal sonography-success rates, repeatability and levels of agreement, Br. J. Radiol., 68, 720, 10.1259\u002F0007-1285-68-811-720\nWhitlow, 1998, The effect of fetal neck position on nuchal translucency measurement, Br. J. Obstet. Gynaecol., 105, 872, 10.1111\u002Fj.1471-0528.1998.tb10232.x\nSchaefer, 1998, The effect of nuchal cord on nuchal translucency measurement at 10-14 weeks, Ultrasound Obstet. Gynecol., 11, 271, 10.1046\u002Fj.1469-0705.1998.11040271.x\nBraithwaite, 1996, Nuchal translucency measurement: training of potential examiners, Ultrasound Obstet. Gynecol., 8, 192, 10.1046\u002Fj.1469-0705.1996.08030192.x\nHerman, 1999, Implementation of nuchal translucency image-scoring method during ongoing audit, Ultrasound Obstet. Gynecol., 14, 388, 10.1046\u002Fj.1469-0705.1999.14060388.x\nWojdemann, 2001, Quality assessment in prospective nuchal translucency screening for Down syndrome, Ultrasound Obstet. Gynecol., 18, 641, 10.1046\u002Fj.0960-7692.2001.00592.x\nSpencer, 2003, Delta-NT or NT MoM: Which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?, Ultrasound Obstet. Gynecol., 22, 142, 10.1002\u002Fuog.186\nCuckle, 2001, Integrating Down's syndrome screening, Curr. Opin. Obstet. Gynecol., 13, 175, 10.1097\u002F00001703-200104000-00013\nSpencer, 1999, A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free-β-human chorionic gonadotrophin and pregnancy-associated plasma protein-A, Ultrasound Obstet. Gynecol., 13, 231, 10.1046\u002Fj.1469-0705.1999.13040231.x\nHyett, 1999, Using fetal nuchal translucency to screen for major cardiac defects at 10-14 weeks of gestation: population based cohort study, BMJ, 318, 81, 10.1136\u002Fbmj.318.7176.81\nWestin, 2006, Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16 383 fetuses, Ultrasound Obstet. Gynecol., 27, 632, 10.1002\u002Fuog.2792\nMaiz, 2008, Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness, Ultrasound Obstet. Gynecol., 31, 256, 10.1002\u002Fuog.5262\nSebire, 1996, Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation, Br. J. Obstet. Gynaecol., 103, 999, 10.1111\u002Fj.1471-0528.1996.tb09550.x\nwww.fetalmedicine.com.\nhttp:\u002F\u002Fwww.orpha.net\u002Factor\u002Forpahnews\u002F2005\u002Fdoc.echofoetale.pdf.\nhttp:\u002F\u002Fwww.hassante.fr\u002Fportail\u002Fupload\u002Fdocs\u002Fapplications\u002Fpdf\u002Fsynthese_evaluation_des_strategies_de_depistage_de_la_trisomie_21.pdf.\nhttp:\u002F\u002Fwww.sihcus-cmco.fr\u002Fpdf\u002FProgramme3D.pdf.\nhttp:\u002F\u002Fwww.sihcus-cmco.fr\u002Fpublic\u002Fclarte_nucale\u002Findex.php.",{"ES":1076},"Translucencia nucal",{"VOID":1078},"10.1016\u002Fs1283-081x(09)70790-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X09707908",[1081,1096],{"id":1082,"sortIndex":115,"researcher":26,"roles":1083,"affiliations":1084,"properties":1093},"b3dabfc2-87c8-48df-a730-60c2f4604846",[696],[1085],{"id":26,"sortIndex":36,"affiliation":1086,"properties":26},{"id":1087,"createTime":1088,"updateTime":1088,"relativeEntities":1089,"slug":26,"properties":1090,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"856826d3-d797-46e8-be61-ca1155ddfdc5","2024-01-19T07:12:19.902+00:00",[],{"title":1091},{"VI":1092},"Département d'échographie et de médecine fœtale, CMCO, 19, rue Louis-Pasteur, 67300 Schiltigheim cedex, France",{"title":1094},{"VI":1095},"R. Favre",{"id":1097,"sortIndex":36,"researcher":26,"roles":1098,"affiliations":1099,"properties":1108},"a7302bfe-c595-4fc4-b644-288a65a621f4",[696],[1100],{"id":26,"sortIndex":36,"affiliation":1101,"properties":26},{"id":1102,"createTime":1103,"updateTime":1103,"relativeEntities":1104,"slug":26,"properties":1105,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8fb84cd2-9878-43e5-90f3-5af932e1780a","2024-01-19T07:12:19.889+00:00",[],{"title":1106},{"VI":1107},"Service de gynécologie-obstétrique, CMCO-SIHCUS, 19 rue Louis Pasteur, 67300 Schiltigheim cedex, France",{"title":1109},{"VI":1110},"A.-S. Weingertner",{"url":1079,"publisher":1112,"properties":1120},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1113,"slug":662,"properties":1114,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1117,"manageAffiliations":1118,"indexDatabases":1119,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1115,"title":1116},{"VOID":665},{"EN":667},[],[],[],{"volume":1121,"pages":1122},{"VOID":1004},{"VOID":1123},"1-10",{"id":1125,"createTime":1126,"updateTime":1126,"relativeEntities":1127,"slug":26,"properties":1128,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1135,"fullTextUrl":26,"authors":1136,"publicationType":747,"publisherRelationship":1352,"citationCount":26,"citationInfo":26,"publishDate":1366,"publishYear":1367,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"5f0225f9-7ccf-4de6-be59-eda5b347064a","2023-12-29T23:27:57.098+00:00",[],{"references":1129,"title":1131,"doi":1133},{"VOID":1130},"Palmer, 1948, La cœlioscopie, Bruxelles Med, 28, 305\nBruhat, 1979, Essai d’un traitement per cœlioscopique de la grossesse extra-utérine : à propos de 26 observations, Rev Fr Gynecol Obstet, 72, 667\nReich, 1989, Laparoscopic hysterectomy, J Gynecol Surg, 5, 213, 10.1089\u002Fgyn.1989.5.213\nBruhat, 1991\nHolzer, 2006, Laparoscopic versus open myomectomy: a double-blind study to evaluate postoperative pain, Anesth Analg, 102, 1480, 10.1213\u002F01.ane.0000204321.85599.0d\nGarry, 2006, Laparoscopic surgery, Best Pract Res Clin Obstet Gynecol, 20, 89, 10.1016\u002Fj.bpobgyn.2005.10.003\nGarry, 1997, Complications of laparoscopic entry, Gynecol Endosc, 6, 319, 10.1111\u002Fj.1365-2508.1997.151-gy0558.x\nQuerleu, 1993, Complications of gynaecological laparoscopic surgery: a French collaborative study, Gynecol Endosc, 2, 3\nChapron, 1998, Surgical complications of diagnostic and operative gynaecological laparoscopy. A series of 29 966 cases, Hum Reprod, 13, 867, 10.1093\u002Fhumrep\u002F13.4.867\nRomanowski, 1993, Brachial plexus neuropathies after advanced laparoscopic surgery, Fertil Steril, 60, 729, 10.1016\u002FS0015-0282(16)56233-5\nShveiky, 2010, Brachial plexus injury after laparoscopic and robotic surgery, J Minim Invasive Gynecol, 17, 414, 10.1016\u002Fj.jmig.2010.02.010\nEteuati, 2013, Brachial plexopathy in laparoscopic-assisted rectal surgery: a case series, Tech Coloproctol, 17, 293, 10.1007\u002Fs10151-012-0920-8\nAgostini, 2010, Patient positioning in laparoscopic surgery: tricks and tips, J Visc Surg, 147, e227, 10.1016\u002Fj.jviscsurg.2010.07.010\nMenes, 2000, Laparoscopy: searching for the proper insufflation gas, Surg Endosc, 14, 1050, 10.1007\u002Fs004640000216\nGutt, 2004, Circulatory and respiratory complications of carbon dioxide insufflations, Dig Surg, 21, 95, 10.1159\u002F000077038\nElkelani, 2004, Effect of adding more than 3% oxygen to carbon dioxide pneumoperitoneum on adhesion formation in a laparoscopic mouse model, Fertil Steril, 82, 1616, 10.1016\u002Fj.fertnstert.2004.07.933\nLarsen, 2004, Randomized clinical trial of the effect of pneumoperitoneum on cardiac function and haemodynamics during laparoscopic cholecystectomy, Br J Surg, 91, 848, 10.1002\u002Fbjs.4573\nAlijani, 2004, Abdominal wall lift versus positive-pressure capnoperitoneum for laparoscopic cholecystectomy: randomized controlled trial, Ann Surg, 239, 388, 10.1097\u002F01.sla.0000114226.31773.e3\nNeudecker, 2002, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery, Surg Endosc, 16, 1121, 10.1007\u002Fs00464-001-9166-7\nMalik, 2000, Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid, Surg Endosc, 14, 452, 10.1007\u002Fs004640000160\nLöning, 2004, Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX, Cancer, 100, 1650, 10.1002\u002Fcncr.20155\nBuchweitz, 2006, Detection of peritoneal endometriotic lesions by autofluorescence laparoscopy, Am J Obstet Gynecol, 195, 949, 10.1016\u002Fj.ajog.2006.02.044\nBarranger, 2016, 3D laparoscopy: an intermediate technology between conventional laparoscopy and robotic surgery contributing to controlling health expenditure, Gynecol Obstet Fertil, 44, 133, 10.1016\u002Fj.gyobfe.2015.11.006\nMartern, 2005, Monitor position in laparoscopic surgery, Surg Endosc, 19, 436, 10.1007\u002Fs00464-004-9030-7\nHaveran, 2007, Optimizing laparoscopic task efficiency: the role of camera and monitor positions, Surg Endosc, 21, 980, 10.1007\u002Fs00464-007-9360-3\nKadar, 1993, Incisional hernias after major laparoscopic gynecologic procedures, Am J Obstet Gynecol, 168, 1493, 10.1016\u002FS0002-9378(11)90787-X\nSinghvi, 2002, Assessment of the physical properties of endoscopic retrieval systems, Br J Surg, 89, 1183, 10.1046\u002Fj.1365-2168.2002.02192.x\nKöchli, 2000, Endobag extractor to remove masses during laparoscopy, Obstet Gynecol, 95, 304\nRabischong, 2013, Long-term complication of laparoscopic uterine morcellation: iatrogenic parasitic myomas, J Gynecol Obstet Biol Reprod, 42, 577, 10.1016\u002Fj.jgyn.2013.07.006\nHarold, 2003, Comparison of ultrasonic energy, bipolar thermal energy, and vascular clips for the hemostasis of small-, medium-, and large-sized arteries, Surg Endosc, 17, 1228, 10.1007\u002Fs00464-002-8833-7\nDiamantis, 2006, Comparison of monopolar electrocoagulation, bipolar electrocoagulation, ultracision, and ligasure, Surg Today, 36, 908, 10.1007\u002Fs00595-006-3254-1\nEmam, 2003, How safe is high-power ultrasonic dissection?, Ann Surg, 237, 186, 10.1097\u002F01.SLA.0000048454.11276.62\nHensman, 1998, Chemical composition of smoke produced by high-frequency electrosurgery in a closed gaseous environment: an in-vitro study, Surg Endosc, 12, 1017, 10.1007\u002Fs004649900771",{"ES":1132},"Laparoscopia y cirugía laparoscópica: principios generales e instrumental",{"VOID":1134},"10.1016\u002Fs1283-081x(18)89352-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X18893523",[1137,1162,1181,1200,1219,1238,1257,1276,1295,1314,1333],{"id":1138,"sortIndex":59,"researcher":26,"roles":1139,"affiliations":1140,"properties":1159},"5b51150b-1fcc-4f40-aad2-9c7d6d2195c3",[696],[1141,1151],{"id":1142,"sortIndex":115,"affiliation":1143,"properties":1150},"b7757eee-75a8-416b-affd-53b228e03161",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1146,"slug":26,"properties":1147,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"51c7dc33-b902-4469-8281-e2575ec5e039","2023-12-29T23:27:57.195+00:00",[],{"title":1148},{"VI":1149},"Centre international de chirurgie endoscopique (CICE), Faculté de médecine, bâtiment 3C, 28, place Henri-Dunant, 63000 Clermont-Ferrand, France",{},{"id":26,"sortIndex":36,"affiliation":1152,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1155,"slug":26,"properties":1156,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5bb93a90-9a54-4256-a939-27a318b724a2","2024-01-27T02:16:05.849+00:00",[],{"title":1157},{"VI":1158},"Service de gynécologie obstétrique et reproduction humaine, CHU de Clermont-Ferrand, CHU Estaing, gynécologie A, 1, place Lucie-Aubrac, 63100 Clermont-Ferrand, France",{"title":1160},{"VI":1161},"A.-S. Gremeau",{"id":1163,"sortIndex":158,"researcher":26,"roles":1164,"affiliations":1165,"properties":1178},"cf3cbd20-1dab-4990-b7a5-9e65d9c6e532",[696],[1166,1173],{"id":1167,"sortIndex":115,"affiliation":1168,"properties":1172},"4f90fcbf-a5af-4275-902e-46acd32474e6",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1169,"slug":26,"properties":1170,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1171},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1174,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1175,"slug":26,"properties":1176,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1177},{"VI":1158},{"title":1179},{"VI":1180},"S. Campagne-Loiseau",{"id":1182,"sortIndex":111,"researcher":26,"roles":1183,"affiliations":1184,"properties":1197},"4dc497a9-8ecf-495e-b0ce-28954a84b752",[696],[1185,1190],{"id":26,"sortIndex":36,"affiliation":1186,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1187,"slug":26,"properties":1188,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1189},{"VI":1158},{"id":1191,"sortIndex":115,"affiliation":1192,"properties":1196},"e97337d3-faa8-4beb-bb72-9dd53ee8669f",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1193,"slug":26,"properties":1194,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1195},{"VI":1149},{},{"title":1198},{"VI":1199},"N. Bourdel",{"id":1201,"sortIndex":116,"researcher":26,"roles":1202,"affiliations":1203,"properties":1216},"d177f8c1-5702-49fd-b8a0-c8dcef470beb",[696],[1204,1211],{"id":1205,"sortIndex":115,"affiliation":1206,"properties":1210},"18d6dfd5-ec1a-4fe5-857f-d1a7d7af7cd5",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1207,"slug":26,"properties":1208,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1209},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1212,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1213,"slug":26,"properties":1214,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1215},{"VI":1158},{"title":1217},{"VI":1218},"R. Botchorishvili",{"id":1220,"sortIndex":36,"researcher":26,"roles":1221,"affiliations":1222,"properties":1235},"426b44a2-0a17-4486-b249-dc457b7833a1",[696],[1223,1230],{"id":1224,"sortIndex":115,"affiliation":1225,"properties":1229},"a9d43de8-a004-4a83-a375-daa4770c4630",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1226,"slug":26,"properties":1227,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1228},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1231,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1232,"slug":26,"properties":1233,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1234},{"VI":1158},{"title":1236},{"VI":1237},"P. Chauvet",{"id":1239,"sortIndex":115,"researcher":26,"roles":1240,"affiliations":1241,"properties":1254},"7ee2d44b-0982-48b3-a8bd-d3380303d706",[696],[1242,1249],{"id":1243,"sortIndex":115,"affiliation":1244,"properties":1248},"b40d15bc-2b8e-4de3-bf8b-cb10c8365a88",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1245,"slug":26,"properties":1246,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1247},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1250,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1251,"slug":26,"properties":1252,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1253},{"VI":1158},{"title":1255},{"VI":1256},"B. Rabischong",{"id":1258,"sortIndex":135,"researcher":26,"roles":1259,"affiliations":1260,"properties":1273},"8ea8a144-a2d1-4fc6-a034-545d357bf7f2",[696],[1261,1268],{"id":1262,"sortIndex":115,"affiliation":1263,"properties":1267},"81fabadd-3ef5-48fe-aea4-f31a4d7d094f",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1264,"slug":26,"properties":1265,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1266},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1269,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1270,"slug":26,"properties":1271,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1272},{"VI":1158},{"title":1274},{"VI":1275},"C. Houlle",{"id":1277,"sortIndex":50,"researcher":26,"roles":1278,"affiliations":1279,"properties":1292},"4abaa0da-1e3f-4cb8-9d68-80333ed2d949",[696],[1280,1287],{"id":1281,"sortIndex":115,"affiliation":1282,"properties":1286},"23642951-7dae-4854-a5fc-057123c2f567",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1283,"slug":26,"properties":1284,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1285},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1288,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1289,"slug":26,"properties":1290,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1291},{"VI":1158},{"title":1293},{"VI":1294},"J.-L. Pouly",{"id":1296,"sortIndex":114,"researcher":26,"roles":1297,"affiliations":1298,"properties":1311},"6c5c1780-bf89-485b-be5b-1276bf0fbf90",[696],[1299,1306],{"id":1300,"sortIndex":115,"affiliation":1301,"properties":1305},"5302a086-db83-4dda-97a8-c0c4302b3577",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1302,"slug":26,"properties":1303,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1304},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1307,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1308,"slug":26,"properties":1309,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1310},{"VI":1158},{"title":1312},{"VI":1313},"S. Curinier",{"id":1315,"sortIndex":52,"researcher":26,"roles":1316,"affiliations":1317,"properties":1330},"50a35d75-166a-457e-aa0f-bc51dc21e5de",[696],[1318,1325],{"id":1319,"sortIndex":115,"affiliation":1320,"properties":1324},"a82c6eb0-30f8-469a-8d98-eb19c1be368a",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1321,"slug":26,"properties":1322,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1323},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1326,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1327,"slug":26,"properties":1328,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1329},{"VI":1158},{"title":1331},{"VI":1332},"M. Canis",{"id":1334,"sortIndex":162,"researcher":26,"roles":1335,"affiliations":1336,"properties":1349},"7abcc593-9406-4a8e-b933-d84ab5352a15",[696],[1337,1344],{"id":1338,"sortIndex":115,"affiliation":1339,"properties":1343},"908396d1-2c1e-464c-8489-eb97a4633d27",{"id":1144,"createTime":1145,"updateTime":1145,"relativeEntities":1340,"slug":26,"properties":1341,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1342},{"VI":1149},{},{"id":26,"sortIndex":36,"affiliation":1345,"properties":26},{"id":1153,"createTime":1154,"updateTime":1154,"relativeEntities":1346,"slug":26,"properties":1347,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1348},{"VI":1158},{"title":1350},{"VI":1351},"A.-G. Kaemmerlen",{"url":1135,"publisher":1353,"properties":1361},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1354,"slug":662,"properties":1355,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1358,"manageAffiliations":1359,"indexDatabases":1360,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1356,"title":1357},{"VOID":665},{"EN":667},[],[],[],{"volume":1362,"pages":1364},{"VOID":1363},"54",{"VOID":1365},"1-17","2018-06-01",2018,{"id":1369,"createTime":1370,"updateTime":1371,"relativeEntities":1372,"slug":1373,"properties":1374,"entityType":688,"verifyStatus":25,"verifyTime":1381,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1382,"fullTextUrl":26,"authors":1383,"publicationType":747,"publisherRelationship":1399,"citationCount":26,"citationInfo":26,"publishDate":1413,"publishYear":1414,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"4e38148a-9f6c-4f79-9b45-71ff71403690","2024-02-08T19:10:08.624+00:00","2025-01-14T13:28:44.322+00:00",[],"Pubertad-precoz",{"references":1375,"title":1377,"doi":1379},{"VOID":1376},"Zacharias, 1976, A prospective study of sexual development in American girls: the statistic of menarche, Obstet Gynecol Surv, 31, 325, 10.1097\u002F00006254-197604000-00026\nHerman-Giddens, 1997, Secondary sexual characteristics and menses in young girls seen in office practise: a study from the Pediatric Research in Office Settings network, Pediatrics, 99, 505, 10.1542\u002Fpeds.99.4.505\nWyshak, 1982, Evidence for a secular trend in age of menarche, N Engl J Med, 306, 1033, 10.1056\u002FNEJM198204293061707\nWhincup, 2001, Age of menarche in contempory British teenagers: survey of girls born between 1982 and 1986, Br Med J, 322, 1095, 10.1136\u002Fbmj.322.7294.1095\nKrstevska-Konstantinova, 2001, Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides, Hum Reprod, 16, 1020, 10.1093\u002Fhumrep\u002F16.5.1020\nZacharias, 1969, Age at menarche, N Engl J Med, 280, 868, 10.1056\u002FNEJM196904172801606\nCarel, 2009, Consensus statement on the use of gonadotropin-releasing hormone analogs in children, Pediatrics, 123, e752, 10.1542\u002Fpeds.2008-1783\nCarel, 2008, Clinical practice. Precocious puberty, N Engl J Med, 358, 2366, 10.1056\u002FNEJMcp0800459\nde Vries, 2010, Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty, J Pediatr, 156, 466, 10.1016\u002Fj.jpeds.2009.09.071\nde Vries, 2006, Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche, Eur J Endocrinol, 154, 891, 10.1530\u002Feje.1.02151\nStanhope, 2003, Gonadotrophin-dependent [correction of dependant] precocious puberty and occult intracranial tumors: which girls should have neuro-imaging?, J Pediatr, 143, 426, 10.1067\u002FS0022-3476(03)00492-X\nChalumeau, 2003, Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule, J Pediatr, 143, 445, 10.1067\u002FS0022-3476(03)00328-7\nVirdis, 1998, Precocious puberty in girls adopted from developing countries, Arch Dis Child, 78, 152, 10.1136\u002Fadc.78.2.152\nKalfa, 2009, Juvenile ovarian granulosa cell tumor: a benign or malignant condition?, Gynecol Endocrinol, 25, 299, 10.1080\u002F09513590802630153\nBrauner, 2010, Clinical, biological and genetic analysis of prepubertal isolated ovarian cyst in 11 girls, PLoS One, 5, e11282, 10.1371\u002Fjournal.pone.0011282\nVölkl, 2006, McCune-Albright syndrome: clinical picture and natural history in children and adolescents, J Pediatr Endocrinol Metab, 19, 551, 10.1515\u002FJPEM.2006.19.S2.551\nMieszczak, 2008, The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome, J Clin Endocrinol Metab, 93, 2751, 10.1210\u002Fjc.2007-2090\nBeas, 1969, Pseudoprecocious puberty in infants caused by a dermal ointment containing estrogens, J Pediatr, 75, 127, 10.1016\u002FS0022-3476(69)80113-7\nGhazi, 1994, Oestrogen and cortisol producing adrenal tumour, Arch Dis Child, 71, 358, 10.1136\u002Fadc.71.4.358\nCarel, 1999, Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment, J Clin Endocrinol Metab, 84, 1973, 10.1210\u002Fjc.84.6.1973\nHeger, 2006, Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function, Mol Cell Endocrinol, 254, 217, 10.1016\u002Fj.mce.2006.04.012\nBouvattier, 1999, Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study, J Clin Endocrinol Metab, 84, 3575, 10.1210\u002Fjc.84.10.3575\nBlanco-Garcia, 1985, Isolated menses in prepubertal girls, Pediatrics, 76, 43, 10.1542\u002Fpeds.76.1.43\nTumini, 2010, Genital sanguineous discharge in prepuberty: a case of mullerian papilloma of vagina in a nine-year-old girl, J Pediatr Endocrinol Metab, 23, 831, 10.1515\u002Fjpem.2010.133",{"ES":1378},"Pubertad precoz",{"VOID":1380},"10.1016\u002Fs1283-081x(12)62739-8","2025-01-14T13:28:44.321+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X12627398",[1384],{"id":1385,"sortIndex":36,"researcher":26,"roles":1386,"affiliations":1387,"properties":1396},"7070dd66-00e7-4c58-ba08-71d260c75f0b",[696],[1388],{"id":26,"sortIndex":36,"affiliation":1389,"properties":26},{"id":1390,"createTime":1391,"updateTime":1391,"relativeEntities":1392,"slug":26,"properties":1393,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"2daa899d-7642-4e78-8a97-99f24bfff10b","2024-02-08T19:10:08.640+00:00",[],{"title":1394},{"VI":1395},"Service d’endocrinologie pédiatrique, Hôpital Bicêtre, Université Paris Descartes, 78, rue du Général-Leclerc, 94270, Le Kremlin-Bicêtre, France",{"title":1397},{"VI":1398},"C. Bouvattier",{"url":1382,"publisher":1400,"properties":1408},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1401,"slug":662,"properties":1402,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1405,"manageAffiliations":1406,"indexDatabases":1407,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1403,"title":1404},{"VOID":665},{"EN":667},[],[],[],{"volume":1409,"pages":1411},{"VOID":1410},"48",{"VOID":1412},"1-5","2012-09-01",2012,{"id":1416,"createTime":1417,"updateTime":1417,"relativeEntities":1418,"slug":26,"properties":1419,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1426,"fullTextUrl":26,"authors":1427,"publicationType":747,"publisherRelationship":1435,"citationCount":26,"citationInfo":26,"publishDate":1448,"publishYear":1449,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"31a7f9d6-93d1-402c-be84-14a37a565937","2023-12-12T01:24:20.491+00:00",[],{"references":1420,"title":1422,"doi":1424},{"VOID":1421},"Lacroix, 2000, Prescription of drugs during pregnancy in France, Lancet, 356, 1735, 10.1016\u002FS0140-6736(00)03209-8\nGarcia, 2000, Prescription médicamenteuse chez la femme enceinte dans le département de la Loire, Therapie, 55, 605\nBeyens, 2003, Prescription of drugs to pregnant women in France: the HIMAGE study, Therapie, 58, 505, 10.2515\u002Ftherapie:2003082\nOlesen, 2006, Associations between socio-economic factors and the use of prescription medication during pregnancy: a population-based study among 19,874 Danish women, Eur. J. Clin. Pharmacol., 62, 547, 10.1007\u002Fs00228-006-0119-x\nEgen-Lappe, 2004, Drug prescription in pregnancy: analysis of a large statutory sickness fund population, Eur. J. Clin. Pharmacol., 60, 659, 10.1007\u002Fs00228-004-0817-1\nAndrade, 2004, Prescription drug use in pregnancy, Am. J. Obstet. Gynecol., 191, 398, 10.1016\u002Fj.ajog.2004.04.025\nLee, 2006, National patterns of medication use during pregnancy, Pharmacoepidemiol. Drug Saf., 15, 537, 10.1002\u002Fpds.1241\nMattison, 2006, Gaps in knowledge in treating pregnant women, Gend Med, 3, 169, 10.1016\u002FS1550-8579(06)80205-6\nGlover, 2003, Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population, Am. J. Obstet. Gynecol., 188, 1039, 10.1067\u002Fmob.2003.223\nNordeng, 2004, Use of herbal drugs in pregnancy: A survey among 400 Norwegian women, Pharmacoepidemiol Drug Sail, 13, 371, 10.1002\u002Fpds.945\nSchirm, 2004, Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system, Eur. J. Obstet. Gynecol. Reprod. Biol., 114, 182, 10.1016\u002Fj.ejogrb.2003.10.024\nHeadley, 2004, Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children, Eur. J. Clin. Pharmacol., 60, 355, 10.1007\u002Fs00228-004-0775-7\nCzeizel, 2009, The estimation of human teratogenic\u002Ffetotoxic risk of exposures to drugs on the basis of Hungarian experience: a critical evaluation of clinical and epidemiological models of human teratology, Expert Opin. Drug Saf., 8, 283, 10.1517\u002F14740330902916459\nBuhimschi, 2009, Medications in pregnancy and lactation: part 1. Teratology, Obstet. Gynecol., 113, 166, 10.1097\u002FAOG.0b013e31818d6788\nAugustine-Rauch, 2007, Alternative experimental approaches for interpreting skeletal findings in safety studies, Birth Defects Res B Dev Reprod Toxicol, 80, 497, 10.1002\u002Fbdrb.20132\nAugustine-Rauch, 2008, Predictive teratology: teratogenic risk-hazard identification partnered in the discovery process, Curr. Drug Metab., 9, 971, 10.2174\u002F138920008786485137\nMohan, 2007, Computer-assisted methods in chemical toxicity prediction, Mini Rev. Med. Chem., 7, 499, 10.2174\u002F138955707780619554\nØstensen, 2009, Management of RA medications in pregnant patients, Nat Rev Rheumatol, 5, 382, 10.1038\u002Fnrrheum.2009.103\nMir, 2010, Taxanes for breast cancer during pregnancy: a systematic review, Ann. Oncol., 21, 425, 10.1093\u002Fannonc\u002Fmdp517\nMawer, 2010, Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study, Seizure, 19, 112, 10.1016\u002Fj.seizure.2009.11.008\n2007, Prakash, Prabhu LV, Nasar MA, Rai R, Madhyastha S, Singh G. Lamotrigine in pregnancy: safety profile and the risk of malformations, Singapore Med. J., 48, 880\nNguyen, 2009, Teratogenesis associated with antibipolar agents, Adv. Ther., 26, 281, 10.1007\u002Fs12325-009-0011-z\nSerreau, 2006, Placental transfer of drugs, 285\nJacqz Aigrain E, Serreau R. Pharmacologie fœto-maternelle : risques des médicaments en cours de grossesse, traitements médicamenteux du fœtus. EMC (Elsevier Masson SAS, Paris), Pédiatrie, 4-002-M-10, 2002 : 7p.\nMenon, 2008, Psychotropic medication during pregnancy and lactation, Arch. Gynecol. Obstet., 277, 1, 10.1007\u002Fs00404-007-0433-2\nWatts, 2007, Teratogenicity risk of antiretroviral therapy in pregnancy, Curr HIV\u002FAIDS Rep, 4, 135, 10.1007\u002Fs11904-007-0020-y\nSoldin, 2008, Triptans in pregnancy, Ther. Drug Monit., 30, 5, 10.1097\u002FFTD.0b013e318162c89b\nKlieger, 2008, Treating the mother--protecting the unborn: the safety of hypoglycemic drugs in pregnancy, J. Matern. Fetal Neonatal Med., 21, 191, 10.1080\u002F14767050801929653\nMir, 2008, Use of platinum derivatives during pregnancy, Cancer, 113, 3069, 10.1002\u002Fcncr.23935\nSchinkel, 1997, The physiological function of drug-transporting pglycoproteins, Semin. Cancer Biol., 8, 161, 10.1006\u002Fscbi.1997.0068\nTanabe, 2001, Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene, J. Pharmacol. Exp. Ther., 297, 1137\nLankas, 1997, P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances vermectin induced neurotoxicity, Toxicol. Appl. Pharmacol., 143, 357, 10.1006\u002Ftaap.1996.8086\nMolsa, 2005, Functional role of P-glycoprotein in the human blood-placental barrier, Clin. Pharmacol. Ther., 78, 123, 10.1016\u002Fj.clpt.2005.04.014\nSmit, 1999, Absence or pharmacological blocking of placental Pglycoprotein profoundly increases fetal drug exposure, J. Clin. Invest., 104, 1441, 10.1172\u002FJCI7963\nAtkinson, 2003, Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer, Am. J. Physiol. Cell Physiol., 285, C584, 10.1152\u002Fajpcell.00418.2002\nNagashige, 2003, Basal membrane localization of MRP1 in human placental trophoblast, Placenta, 24, 951, 10.1016\u002FS0143-4004(03)00170-X\nHooijberg, 2004, Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1), Biochem. Pharmacol., 67, 1541, 10.1016\u002Fj.bcp.2003.12.022\nIfergan, 2004, Folate deprivation results in the loss of breast cancer resistance protein (BCRP\u002FABCG2) expression: a role for BCRP in cellular folate homeostasis, J. Biol. Chem., 279, 25527, 10.1074\u002Fjbc.M401725200\nGennuso, 2004, Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1), Proc. Natl. Acad. Sci. USA, 101, 2470, 10.1073\u002Fpnas.0308452100\nMadon, 2000, Transport function and hepatocellular localization of mrp6 in rat liver, Mol. Pharmacol., 57, 634, 10.1124\u002Fmol.57.3.634\nSt-Pierre, 2000, Expression of members of the multidrug resistance protein family in human term placenta, Am. J. Physiol. Regul. Integr. Comp. Physiol., 279, R1495, 10.1152\u002Fajpregu.2000.279.4.R1495\nGunshin, 1997, Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature, 388, 482, 10.1038\u002F41343\nAllikmets, 1998, A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance, Cancer Res., 58, 5337\nMiyake, 1998, Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone- resistant cells: 7 breast cancer cells, Proc. Natl. Acad. Sci. USA, 95, 15665\nAFSSAPS. Rappel sur la contre-indication des antagonistes des récepteurs à l'angiotensine II au cours des 2es et 3es trimestres de grossesse, lettre aux prescripteurs, juin 2003, agmed.sante.gouv.fr\u002Fhtm\u002F10\u002Ffilltrpsc\u002Flp030602.htm.\nSerreau, 1999, Developmental toxicity of the angiotensine II type 1 receptor antagonists human demonstration of homology to ABC transport genes, Cancer Res., 59, 8\nDoyle, 2005, A multidrug resistance transporter from human MCF- pregnancy a report of 10 cases, BJOG, 112, 710\nMartinovic, 2001, Fetal toxic effects and angiotensin-II-receptor antagonists, Lancet, 358, 241, 10.1016\u002FS0140-6736(01)05426-5\nRamasubbu, 2004, Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review, J. Clin. Psychiatry, 65, 1642, 10.4088\u002FJCP.v65n1209\nGuittin, 2002, Future improvements and implementation of animal care practices within the animal testing regulatory environment, ILAR J., 43, S80, 10.1093\u002Filar.43.Suppl_1.S80\n2005, Prescrire. « Éviter les rétinoïdes en application cutanée pendant la grossesse, Rev Prescrire, 25, 106\nRecommandations médicaments et grossesse du dictionnaire Vidal® (accès libre ; mise à jour : 12 novembre 2009) avec les références et sites internationaux ; arbre décisionnel.\nwww.vidalrecos.fr\u002Fpages\u002Findex.php?idannexe=2585&titre=Prescription_et_populations_particulieres_Medicaments_et_grossesse&prov=acc.\nAfssaps – octobre 2009 – actualité thalidomide et plan de gestion de risque www.afssaps.fr\u002Fvar\u002Fafssaps_site\u002Fstorage\u002Foriginal\u002Fapplication\u002F47fdcdc60cd555fe67ba5ba652a36495.pdf.\nCentre de références sur les agents tératogènes (CRAT) www.lecrat.org\u002F.\nIconographie d'un hypocalvaria fœtal après une exposition in utero aux IEC : http:\u002F\u002Fjasn.asnjournals.org\u002Fcgi\u002Freprint\u002F3\u002F9\u002F1575.\nDysgénésie rénale après exposition IEC ou sartans : www.humpath.com\u002Frenal-tubular-dysgenesis.",{"ES":1423},"Teratología y uso de medicamentos durante el embarazo",{"VOID":1425},"10.1016\u002Fs1283-081x(11)71084-0","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X11710840",[1428],{"id":1429,"sortIndex":36,"researcher":26,"roles":1430,"affiliations":1431,"properties":1432},"1a90059d-f00e-4d93-b772-61e905070016",[696],[],{"title":1433},{"VI":1434},"R. Serreau",{"url":1426,"publisher":1436,"properties":1444},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1437,"slug":662,"properties":1438,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1441,"manageAffiliations":1442,"indexDatabases":1443,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1439,"title":1440},{"VOID":665},{"EN":667},[],[],[],{"volume":1445,"pages":1447},{"VOID":1446},"47",{"VOID":1123},"2011-01-01",2011]